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Abstract
The hospice care population with cancer are often older adults who report many cancerrelated symptoms experienced often in clusters. Most prevalent of these symptoms is fatigue and often it
co-occurs with depressive symptoms and poor physical functioning. This dissertation examined

fatigue, symptom clusters, depression, physical activity, and functional status in older adults with
cancer. The aims of the literature review were to understand the relationship among physical
functioning, cancer fatigue, fatigue-related symptom clusters, and their relationship with
functional status In older adults. The literature related to these associations is insufficient and
inconclusive. The methods section aimed to investigate the reliability and validity of the Center
for Epidemiology Studies-Depression scale, Boston Short Form (CESD-10). Using Structural
Equation Modeling (SEM) for confirmatory factor analysis, the factor structure of responses in a
cross-sectional sample (N = 200) of adults with different types and stages of cancer was
examined. Internal consistency reliability estimate Cronbach’s alpha = 0.737. The CESD-10 fourfactor model (positive affect, depressive affect, somatic complaints, and interpersonal
challenges) fits the data well. The CESD-10 was a valid and reliable measure for assessing
depressive symptoms in this study. The final section examined fatigue related symptom clusters
and their relationships with functional status in older adult hospice patients with cancer (N=519).
The fatigue-related symptom cluster (lack of energy, feeling drowsy and lack of appetite),
significantly predicted poor functional status. Experiencing physical and psychological
symptoms has a significant impact on functional dependence. Hospice healthcare professionals
should be alert to older adults’ symptom cluster experience during assessment and management.
vi

Dissertation Overview
Introduction
In 2018, over a 1.7 million new cancer cases and more than 609,000 cancer deaths are
estimated to occur in the United States (Siegel, Miller, & Jemal 2018). The anticipated
demographic changes of the U.S. are derived from the rapidly aging population. By 2030, new
cancer diagnoses are projected to reach 2.3 million a year, approximately (60%) of those
patients, and up to 70% of all cancer mortality will be occurring in 65 years of age or older
(Smith, D., Smith, L., Hurria, Hortobagyi, & Buchholz, 2009). This estimated dramatic spike in
cancer incidence of older adults in future cancer population will shift the healthcare system and
the direction of research, towards new cancer therapies and care pathways. Which in turn creates
a need for further investigations of cancer symptom science, to solidify older people’s health
care approach toward optimum quality of life (QOL).
Fatigue in Older Adult Cancer Population
Fatigue is one of the most prevalent, persistent, and distressing symptoms experienced by
older adult patients across the cancer trajectory (Beck, Towsley, Caserta, Lindau, & Dudley,
2009; Luctkar-Flude, Groll, Woodend, & Tranmer, 2009). A significant number of those older
adults with cancer exhibit functional impairment (Jacobson, 2013; Garrison et al., 2011). When
compared to their younger counterparts, older adults with cancer often present with other chronic
illnesses, such as arthritis, myalgia, and insomnia. These co-morbidities dispose them with great
risks of psychological distress, depression, limited functional status with manifestation of
constrained overall performance status and inability of carrying out activities of daily living
1

(Barbera et al., 2010; Beck et al., 2009; Luctkar-Flude et al., 2009; Giacalone et al., 2013;
Hellstadius et al., 2016; Palgi, Shrira, & Zaslavsky, 2015; Rha & Lee, 2017). Nevertheless, over
75% of the studies in recent systematic reviews failed to report co-morbidities and appeared to
discount the importance of evaluating multimorbidities and fatigue-related symptoms
relationship with functional status (Cramp & Byron-Daniel, 2012; Puetz & Herring, 2012;
Mishra et al., 2012; Rha & Lee, 2017).
Researchers have repeatedly identified that fatigue is at the center of the cancer
symptoms experience, especially in symptom cluster research (Van Lancker, Beeckman,
Verhaeghe, Van Den Noortgate, & Van Hecke, 2016; Yeo et. al, 2012). Older adult patients
with cancer often present with an accentuated fatigue experience secondary to such experience
that interferes with their physical/psychological well-being and QOL (Beck et al., 2009; LuctkarFlude et al., 2009). Research findings show consistent symptom clusters that are most relevant to
cancer fatigue including pain, sleep disturbance, anorexia, dyspnea, and gastrointestinal
(constipation, nausea, and diarrhea) complications (Tsai, Wu, Chiu, Hu, & Chen, 2006; Van
Lancker et al., 2016). However, in addition to the physical symptoms, psychological distress
and/or depression are more often co-occurring in the fatigue symptom clusters and found to
increase cancer fatigue experienced (Hwang, Cho, & Yoo, 2016; Nho, Kim, & Nam, 2017; Tsai,
Wu, Chiu, & Chen, 2010)). A broad range of cancer studies, with different genders, ages, and
various cancer stages, notably identified the correlation between psychological symptoms,
fatigue, and functional status (Rha & Lee, 2017; Van Lancker et al., 2016). Recent and ongoing
investigations consistently conclude that high psychological distress and lack of social support
has a direct impact on physical deterioration of the patient, no matter what form of cancer, or
which symptom cluster (Okuyama et al., 2008)). Understanding the importance of these fatigue-
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related clusters in older adults with cancer is integral to future interventions, treatments, and
care.
Symptom Clusters
Understating symptoms is essential in palliative care. Much research in this area is still
needed. Throughout the terminal cancer stages, specific symptom clusters and their proper
identification are often overlooked. Recent research in the ladder phases of advanced cancer and
older adult patients indicates more attention is needed to the details of the symptoms within the
clusters. Van Lancker et al., (2016) compared older adults in geriatric hospital units to those in
non-geriatric units in a cross-sectional study. Four hundred palliative patients with cancer were
evaluated using validated and agglomerated clustering studying the physical, psychological,
functional, social and existential aspects of their experience. Results from this study indicated a
need for more acute attention to the analyzing of symptoms within clusters that would better
distinguish a patient symptom experience from the other in order to provide more personalized
and accurate care. In this case, 3 patient groups were identified as 1) symptom-free 2) physical
discomfort 3) physical and psychological discomfort. Group 3 had a significantly higher geriatric
risk profile on their functional dependency in tandem with feeling less meaning in their lives,
prone to or with depression and other psychological disorders. This reflects a stronger need to
better assess the impact that the psychosocial dynamic has on both the physical symptoms which
cluster with cancer fatigue and their predictability of functional status or lack thereof.
Further supporting the connection between the psychological and physical discomforts, a
study conducted by Okuyama et al., (2008) stresses that fatigue, a primary symptom of the
terminal cancer spectrum, was found to be much more severe when coupled with psychological
distress. Greater fatigue was directly correlated with psychological distress indicating the
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importance of psychological intervention in the inclusion of treatment and care for fatigue and
its’ associated symptoms. Conversely, Hui, dos Santos, Chisholm, and Bruera, (2015), found that
depression dissipates while increasing discomfort and pain continue to persist. This study,
assessing symptoms during the last seven days of the life, suggests that it is precisely the
detachment from depression experience could serve as a predictor of pending death. Therefore,
this study reinforces the priority and urgency to focus on the psychosocial and mental experience
of the palliative care patients, in equal tandem with all of the psychological symptoms,
throughout all crucial phases from their admission into hospice care.
Alternatively, Tsai et. al, (2006) assessed symptom clusters in cancer patients of the lung,
liver, stomach, the most prevalent symptoms identified were fatigue, weakness, anorexia,
abdominal/gastrointestinal pain, and depression. Following this, the authors undertook a deeper
investigation into the change patterns of severity between one week after admission and two days
before death. Six clusters were identified, and their severity was measured against the time
frames from admission to their death. This study demonstrated that the most prevalent symptom
clusters (gastrointestinal complications, insomnia, depression, and aggression) with an emphasis
on both physical and psychological symptoms, were improved through palliative care. On the
other hand, fatigue was in the group associated with anorexia and dyspnea and showed no
improvement. The conclusion from this study once again emphasizes a stronger focus needed,
not just on symptom management, but a holistic approach that will equally tend to the
psychosocial and spiritual dynamic of the patients near the end of life experience.
Symptom Clusters, Functional Status, and Quality of Life
Identifying symptoms within symptom clusters supports the imperative to define QOL.
This is the primary objective, and most rational solution, for palliative care and anyone in the late
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stages of their lives. There is a lack of longitudinal studies to understand relationships between
symptom clusters, functional status, and QOL. Prior research has focused on the cluster
symptoms, rather than symptoms within the clusters; this leads to a tendency to over-generalize
the concept of functional status impact on QOL. Ongoing investigations have supported this need
to distinguish. Two earlier studies of ovarian cancer patients identified specific symptom clusters
as a result of the cancer disease itself and the cancer therapy (Hwang et al., 2016; Nho et al.,
2017). In the Hwang (2016) study, prevalent symptom clusters were found to include fatigue,
depression, psychological distress, and abdominal discomfort; its effects were amplified by
patients with high depression. These clusters influenced all aspects of their QOL. In the other
study Nho et al. (2017) deciphered two clusters. The first cluster was anxiety, depression,
fatigue, sleep disturbances. The second cluster was pain and chemotherapy-related symptoms. It
was the combination of both that led to the poorer QOL. That said, both studies concluded that,
while the symptom clusters varied depending on age, onset, disease duration, recurrence, the
combination of physical with emotional symptoms did indeed affect the overall quality of the
ovarian cancer patients’ lives. While this may seem an obvious conclusion, palliative care
research is now lending itself to more definitive observations on the impact of psychosocial wellbeing amidst the specific symptom clusters, leading to better ways to predict and manage
functional status.
In a more recent study that determined differential contributions of symptom cluster to
functional status and QOL, Rha & Lee (2017) assessed 300 patients undergoing palliative
chemotherapy. Four symptom clusters were identified, while nausea/vomiting/appetite symptoms
were categorized with a poor emotional experience to negatively affect the role and social
functioning, fatigue and its’ correlated cluster symptoms such as dyspnea, constipation, and sleep
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disorders negatively affected physical functioning. Role functioning was found to have a direct
impact on QOL. All of the other symptom, symptom clusters and/or subsets of symptoms
indirectly impacted QOL, these symptoms included both physical and psychosocial symptoms.
Once again, these findings support the urgency to understand the coupling of psychological
distress, such as depression, with the recurring physical symptoms. The psychosocial dynamic
seems to be a prevalent predictor to negatively affect both functional status and QOL. Similarly,
another study concluded severity of psychological distress as having a direct and immediate
impact on physical deterioration (Tsai et al., 2010).
Depression
Depression is one of the most important symptoms at the time of hospice admission
(Garrison et al., 2011; McMillan, Small, & Haley, 2012). Progressively close to the end of life,
greater losses may become at stake including relationship connections, personal privacy, dignity,
freedom, liberty, and independence, as well as cognitive and physical capacity. In response to
such suffering, many of cancer patients endure a significant emotional distress. (Choi, Ransom,
& Wyllie, 2008). This normal response to tragic life events is a part of a spectrum of depressive
symptoms which range from normal feelings of sadness to adjustment disorder with depressed
moods or a full-blown major depression (Rhondali et al., 2012; Widera & Block, 2012). Living
with chronic stress response had been linked to increased mortality in cancer patients. Such
adversities include reduced body tumor surveillance, reduced tumor suppressor gene activity,
and cellular apoptosis, and increased cancer invasiveness (Smith 2015). Neglecting depression
assessment and management in hospice care settings can be equated with hastening death in this
population.
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Despite the highlighted demand for a change in detecting depression in the cancer
population, recent studies showed that psychosocial assessments for depression were missing
about 75% of the time from hospice patient’s records (McMillan et. al, 2012). According to the
National Comprehensive Cancer Network (2018), only about 5% of the patients with cancer
obtain psychological care (Watson et al., 2016). Besides the stigma associated with mental
illness, researchers report that a likely barrier to the adequate diagnosis and treatment of
depression is a common belief that experiencing depression is universal at the end of life
(Widera & Block, 2012). The underdiagnosis of depression was not attributed to the clinicians’
lake of knowledge or care providers’ neglect, Rhondali et al., (2012) suggested the lack of time
as reported by oncology palliative care clinicians is an important factor. Perhaps the fast and
busy clinical pace of the work environment urged the move towards electronic symptom
screening both nationally and internationally (Burstin, Leatherman, & Goldmann, 2016).
However, active management of depression and systematic assessments of depression in hospice
remains inadequate and difficult to implement (McMillan et. al, 2012; Rhondali et al., 2012).
Depression can worsen the overall symptom burden, it affects the patient’s ability to
adhere to treatment recommendations, it affects how people cope with their cancer, and
adversely affects not only the patient’s but also the patient’s family and caregivers’ QOL (LloydWilliams, Dennis, & Taylor, 2004; Lloyd-Williams, Shiels, Taylor, & Dennis, 2009; Satin,
Linden, & Phillips, 2009). The issues with depression in older adults with cancer are very unique
compared to the general cancer population. Older adults experience depressive symptoms
differently, unexplained physical complaints such as fatigue and headaches, or sleep disturbances
are often a sign of depression in this age group, rather than feeling sad or depressed. Also, they
may appear confused, have memory loss, or be agitated. Delirium is also common (90%) among
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older adults with advanced disease in the final days of life, making it even more challenging for
detecting depression in the hospice population with cancer (Nelson, et al., 2010). In addition,
when it comes to assessing depression, there’s the challenge of choosing the most appropriate
instrument for this group. Many depression measures have been validated for use with the
general population of older adults, and with patients with cancer, however, there are fewer
reported data on the validity and reliability of these most commonly used instruments in older
adult hospice patients with cancer (Marks & Heinrich, 2013).
Moreover, prior hospice research on depression and symptom assessments had focused
on studying symptoms separately rather than exploring how different symptoms co-occur in
certain patterns (i.e. symptom cluster) and how they interact and influence each other (LloydWilliams et al., 2017; Widera & Block, 2012). While hospice care is covered by Medicaid and
most private insurance plans, approximately 85% of enrollees receive hospice coverage through
the Medicare hospice benefit. Quality and effective utilization and management of government
resources are warranted. All health organizations are called out for better and innovative
measures to detect depression. Understanding symptom clusters, how they can influence each
other, and how they predict certain health-related outcomes may contribute to improving
symptoms assessment in hospice care settings.
This dissertation research seeks to discern the myriad symptoms experienced by older
adult cancer patients in hospice care. There are three sections/manuscripts in this dissertation.
Using this proposed model, this dissertation will examine the associations among fatigue-related
symptom clusters (physical symptoms), functional status, and depression (psychological
symptoms) in older adults with cancer in hospice. In the first section of the dissertation, an
integrative review is presented that was to understand the effect of physical activity interventions
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that improved fatigue and functional status in older adult cancer population (Title: Physical
Activity, Cancer-related Fatigue, and Functional Status in Older Adults with Cancer: A Review
of Literature). In the second section, a psychometric evaluation of a clinical relevant depression
scale (CESD-10) is described while depression is considered as the psychological symptom in
the conceptual model (Title: Validity and Reliability of the Center for Epidemiologic Studies
Depression, Boston Short Form: A Clinically Relevant Scale for Depression Detection in Cancer
Patients. In the third section, the fatigue-related cluster is identified. Its relationships with
functional status and depression are examined and confirmed (Title: Fatigue-Related Symptom
Clusters, Depression and Functional Status of Older Adults in Hospice).
Definitions of Relevant Terms
For the purpose of this study, the following terms and definitions were used.
1. Fatigue in cancer: A physical symptom; an unusual, sustained, subjective sense of
tiredness, malaise or lack of energy, related to cancer or cancer treatment that
interferes with usual functioning (The National Comprehensive Cancer Network
[NCCN], 2018).
2. Depression: A psychological symptom; includes a series of depressive symptoms
such as lack of energy, inability to concentrate, lack of interest and pleasure in daily
activities, significant weight loss or gain, insomnia or excessive sleeping, feelings of
worthlessness or excessive guilt and recurrent thoughts of death or suicide (American
Psychological Association, 2018).
3. Symptom cluster: The presence of a group of related co-occurring symptoms which
may not have a shared etiology but can have a combined effect on outcomes as
patient’s morbidity (Miaskowski, Aouizerat, Dodd & Cooper, 2007).
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4. Physical activity: a bodily movement produced that requires energy expenditure as a
part of a structured or prescribed exercise intervention (World Health Organization,
2018).
5. Functional status: A functional measure that attempts to estimates the patients’
general well-being and ability to independently perform activities of daily living.
6. Older adults: The World Health Organization (2010) defines older age based on a
range of characteristics including the change in social role and functional abilities.
For the purpose of this research older adults are defined as: adults 65 of age and
older.
7. Hospice: A facility which delivers hospice care programs and services designed to
provide palliative care and emotional support to the terminally ill in a home or homelike setting where symptoms are controlled, and QOL is maintained. cite
Theoretical Background
Clinical experts and researchers alike have an agreement concerning the symptom
cluster phenomenon in patients with cancer (Agasi-Idenburg, Thong, Punt, Stuiver, & Aaronson,
2017; Nieder & Kämpe, 2017; Nho et al. 2017; Reich et al., 2017; Van Lancker et al., 2016). The
focus on symptom cluster research steams from the innovations and advances in science and
cancer therapies (Aktas, Walsh, & Rybicki, 2010; Dong et al., 2016; Yeh, Chien, Lin, Bovbjerg,
& Van Londen, 2016). A key principle of the Theory of Unpleasant Symptoms (Lenz, Suppe,
Gift, Pugh, & Milligan, 1995), is that multiple disease-related symptoms often occur
simultaneously and have interactive and adversative interaction. In cancer research, this premise
is supported by findings indicating the worst fatigue and sleep quality were related to the most
severe pain (Lenz, Pugh, Milligan, Gift, & Suppe, 1997). Patient factors influencing the
symptom experience include age, living arrangement disease stage, and months from diagnosis.
10

The outcome of the symptom experience is conceptualized as functional status. In summary, the
Theory of Unpleasant Symptoms helps guide the current study by providing a framework that
postulates (1) cancer symptoms are interrelated; (2) patient contextual factors influence the
experience of physical and psychological symptoms and fatigue-related symptom cluster; (3)
Functional status is an outcome of the symptom experience.
Behavioral Logical Model:
To answer the research questions and test the proposed theoretical relationships a
conceptual framework that integrates the selected constructs of fatigue-related symptom clusters
(FSC) of participation, and functional status is presented (Figure 1). Using a logical model, the
relationships among the factors of FSC (physical and psychological symptom) and predictors of
functional status (outcome) are delineated.

Contextual Variables
Demographic
factors
Age
Gender
Marital Status
Ethnic Background
Education
Employment
Living arrangement
Clinical Factors
Cancer Diagnosis
Years since
Diagnosis
Cancer Symptoms

Cancer Symptoms

Fatigue-related
symptom cluster

Outcomes

Functional
Status

Depression

Figure 1. Directional pathways of fatigue-related symptoms and functional impairment with
psychosocial, behavioral, and physiological variables.
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Statement of the Problem
Patients in hospice care who were treated with surgery, radiation or chemotherapy and
are in advanced or terminal stages of their cancer illness, often experience an array of distressing
symptoms that occur simultaneously in clusters (Kirkova, Walsh, Aktas, & Davis, 2010). Over
one-third of patients with cancer experience symptoms significantly. Among these symptoms,
fatigue has been the most frequent, severe, and distressing symptom reported (Beck et.al, 2009;
Luctkar-Flude et. al, 2009). More importantly, a mix of fatigue, depression, sleeplessness, and
poor appetite renders them with a struggle to carry activities of daily living, a decline in
functional status (Dodd, Cho, Cooper, & Miaskowski, 2010). Functional status operationally
defined by performance was significantly influenced by fatigue and/or fatigue-related symptom
cluster.
When the purpose of hospice care is to alleviate suffering and maximizing the QOL for
the patients who are in the last phases of an incurable disease, focusing on detecting symptom
cluster should be a priority. Many studies which addressed older adult functional status in
patients with cancer included patients who are cancer survivors or have an early-stage disease
(Beck et.al, 2009; Luctkar-Flude et. al, 2009; Sprod et al., 2012). There is limited research on
predictors of functional status in hospice settings. Few nursing studies report the percentage of
the population with advanced disease, and even fewer included patients near the end of life or
those receiving hospice care services (Dy et al., 2012; Garrison et al., 2011). There is a need to
explore whether the functional status is influenced by the experience of FSC in hospice patients
with advanced cancer disease. Several studies concluded that more than half of all patients with
advanced cancer disease who are receiving treatment experience co-occurring symptoms
(Delgado-Guay, Yennurajalingam, Parsons, Palmer, & Bruera, 2011; Nho et al., 2017; Nieder &
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Kämpe, 2017). The stability of symptom clusters remains unclear, whether patients with
advanced cancer continue to experience similar fatigue-related symptom clusters after
transitioning to hospice care is an area in need of further nursing research.
Significance to Nursing Research
Identifying the fatigue-related symptom cluster and understanding its relationship with
functional status and depression, in older adult hospice patients, will inform fatigue symptom
management interventions so that nursing researchers will be able to detect what other symptoms
in the cluster are likely to change. The desired symptom cluster research outcome is similar to
novel treatments, which aim to manage several symptoms by targeting their common pathway.
Living in chronic stress response had been linked to reduced lifespan in patients with cancer
(Smith, 2015; Denieffe, Cowman, & Gooney, 2014). Considering symptom clusters as a major
source of chronic stress in the hospice patients, this study will inform the future symptom cluster
researcher priorities and the clinical practice of every compassionate nurse who strives to make a
difference in older adult lives.
Implications for Clinical Practice
While hospice care is covered by various public and private insurance plans,
approximately 85% of enrollees receive hospice coverage through the Medicare hospice benefit
(National Hospice and Palliative Care Organization: Facts and Figures Hospice Care in America,
2016). Quality and effective utilization and management of government resources are warranted.
All health organizations are called out for better and innovative measures to detect health
outcomes. Experiencing cancer symptoms in clusters can worsen the overall symptom burden as
it extenuates symptom distress, it affects the patient’s ability to adhere to treatment
recommendations, how people cope with their cancer, and adversely affects not only the
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patient’s but also the patient’s family and caregivers’ QOL (Stapleton, Hplden, Epstein, &
Wilkie, 2016; Lloyd-Williams et al., 2009; Satin et al., 2009). Understanding fatigue-related
symptom clusters, how they relate to each other, and how they influence functional status may
contribute to improving older adults’ symptom assessment and management in hospice care
settings.
The use of symptom cluster analysis to predict and detect functional status is a
contemporary approach to utilizing health information, it will contribute to the enhancement of
hospice and palliative care clinicians’ sensitivity for identifying risk factors, and older adults at
risk for impaired cognitive or physical capacity (Widera & Block 2012). Also, it will help
promote and advance the statistical methods and assessment tools use for cancer-related
symptom cluster research (Aktas, Walsh, & Hu, 2014; So et al., 2009). In addition, fatiguerelated symptom cluster is considered as a physical symptom relating to functional status while
depression is defined as a psychological symptom with confounding effects in this relationship.
This study will shed light on symptom predictors of functional status, it will provide an
understanding of the risk factors that warrant initiating referrals and appropriate interventions to
optimize health outcomes and reduce the potential symptom distress among older adult hospice
patients with cancer.
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Section One: Physical activity, fatigue, and functional status in older adults with cancer.
A Review of Literature
Abstract
More than half of the older adults with cancer report fatigue as the most common
symptom that is experienced with moderate to severe intensity most of the time, and often is
complicated with concurrent symptoms and comorbidities. We undertook a systemic review of
the current literature to summaries the evidence exploring fatigue-related symptom cluster, and
what relationships, if any, exist between fatigue, physical activity, and functional status. To
synthesize data about older adults’ fatigue and functional status, systematic reviews are included
in the narrative of the literature in this area from 2011 to 2018.
Empirical evidence supports the benefits of physical activity for the management of
cancer fatigue and improving physical functioning in the older adult cancer population.
Multimodal interventions including aerobic and resistance exercises showed significant
improvements in cancer fatigue. Future research is warranted to determine the most effective
physical activity parameters for fatigue in older adults with cancer including intensity level,
duration, and frequency of sessions. Consensus on the most appropriate fatigue outcome measure
also is needed as are studies that are sufficiently powered to detect changes in fatigue. Further
work should include patients with advanced disease who are receiving palliative care. This
review concluded a need for further research regarding comprehensive physical activity
interventions for the management of cancer fatigue. in older adults with cancer in hospice care.
Keywords: palliative care, exercise, physical functioning, symptom cluster, frail.
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Introduction
Clinically, fatigue in cancer is highly distressing, and prevalent, occurring in about 70%
of older adults with cancer. If left unmanaged fatigue can compromise patients’ functional status
in a way that alters their health-related quality of life and changes their lives forever. Given that
fatigue is almost never occurring in isolation, both physical and psychological factors associated
with fatigue have been implicated in increased suffering, increased symptom intensity and
burden reduced treatment adherence and ultimately reduced survival time. Increasing physical
activity and committing to exercise is highly recommended as an effective non-pharmacological
intervention for the management of fatigue during the cancer continuum (Agasi-Idenburg,
Thong, Punt, Stuiver, & Aaronson, 2017; Barbera et al., 2010; Deckx et al., 201; Giacalone et al.,
2013; Van Lancker, Beeckman, Verhaeghe, S., Van Den Noortgate, & Van Hecke, 2016;
National Comprehensive Cancer Network, 2018; Palgi, Shrira, & Zaslavsky, 2015; Rock et al.,
2012; Sprod et al., 2012; Yennurajalingam et al., 2016).
There are tangible benefits of physical activity when it comes to cancer symptom
management. Physical activity is associated with significantly reduced fatigue during and after
the course of cancer treatment and has beneficial effects on functional status and quality of life
(QOL). Physical activity also is recommended for its’ significant beneficial effect on depression
and pain as well as the sleep disturbances and older adults’ cognitive health integrity. However,
such an effective intervention is yet to be explored when addressing fatigue as a symptom cluster
with multiple co-existing symptoms. Aging is typically associated with a decline in functional,
physical, and cognitive conditions, and when exposed to cancer treatments(Beck, Towsley,
Caserta, Lindau, & Dudley 2009; Costarella, Monteleone, Steindler, & Zuccaro, 2010; Cramp &
Byron-Daniel, 2012; Davis & Goforth, 2014; Fuller, Hartland, Maloney, & Davison, 2018;
Northey, Cherbuin, Pumpa, Smee, & Rattray, 2018; Payette et al., 2011; Puetz & Herring, 2012).
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Older adults experience a rapidly progressive debility, which consequently has detrimental
effects on their physical and psychological well-being,
In a Cochrane Collaboration Review, 56 randomized controlled trials (RCTs) of physical
activity interventions for 4068 adults were included and investigated their effectiveness for
fatigue (Cramp & Byron-Daniel, 2012). This meta-analysis published in 2012, included
randomized controlled trials (RCT) published between 1861 and 2011. The authors found that
aerobic exercise was effective and beneficial for the management of fatigue; however, only one
reported RCT was conducted specifically for an older adult population (mean age 65) who were
all diagnosed with breast cancer (Payne, Held, Thorpe, and Shaw, 2008). More recently, a group
of 20 older women with cancer (mean age = 62) were examined during a cancer rehabilitation
exercise program (Smith, Broomhall, and Crecelius, 2016). The study evaluated the impact of
moderate levels of physical activity on functional status, cancer-related symptoms of fatigue and
depression, and QOL. Participants attended 12-sessions of supervised aerobic and resistance
training, for an hour, twice weekly during a 6- to 10-week period. The authors found that all
functional status tests improved significantly, including aerobic endurance and muscle strength
and endurance. Also, QOL was improved significantly, however, neither fatigue nor depression
had a detectable change.
It is time to investigate whether there is an update of literature with regards to new
evidence relevant to older adult people with cancer, or any missed trials that have been published
since 2011. This integrative review aimed to understand, in the physical activity RCTs among
older adults, (1) measurement of fatigue in older patients (2) physical activity interventions that
mitigated fatigue symptom, and (3) physical activity interventions that improved functional
status.
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Method
A systematic computer-aided search using PubMed, Web of Science, and PsychINFO,
was completed (05.01.2018). The search terms used for each database were cancer-related
fatigue AND physical activity, OR physical exercise, AND functional status, OR performance
status, AND older adults OR elders OR geriatrics. In total 1,647 articles were screened (Figure
2), title and abstract of the articles were examined to determine their relevance to this review;
then the full-text articles were assessed for the adherence to the inclusion criteria Reference lists
from the retrieved articles were also screened for relevant publications which may have been
missed by the computer-aided search.
Inclusion and exclusion criteria.
To be included in this review studies had to be: (1) articles published in the English
language; (2) primary research articles conducted in the United States; (3) RCTs with physical
activity interventions; (4) articles published after 2011; (5) participants were older-adults (≥65
years of age), either women or men diagnosed with cancer; (6) articles examining fatigue and/or
functional status as an outcome; and (7) articles published in peer-reviewed journals. Exclusion
criteria included: (1) animal model trials;(2) non-adult human studies; (3) abstract-only articles;
(4) case studies; and (5) unpublished studies. The study selection, data extraction, and screening
were verified using the inclusion and exclusion criteria.
Results
Nine randomized controlled trials (RCTs) with physical activity interventions (Table 1)
were included (Bourke et al., 2011a, 2011b; Culos-Reed et al., 2010; Edvardsen et al., 2015;
Galvão, Taaffe, Spry, Joseph, and Newton 2010; Hawkes et al., 2013; Oldervoll et al., 2011;
Wenzel et al., 2013; Yeo et al., 2012).
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Identification

Records identified through database
searching
(n = 1548)

Additional records identified
through other sources
(n = 59)

Included

Eligibility

Screening

Records after duplicates removed
(n = 1259)

Records screened
(n = 228)

Full-text articles assessed
for eligibility
(n =12)

Records Excluded (n=1031)
Not published in English
(n=17)
Review articles (n=439)
Publication date > 2011
(n=569)
Animal model trials (n=6)
No abstract available (n=)
Duplicate
Full-text articles Excluded
(n=216)
Non-adult human studies = 3
Age < 60 = 57
No PA intervention = 18
No Fatigue outcome = 29
Non RCT = 78
Confounding factors = 16
Full-text irretrievable = 12

Studies included in
quantitative synthesis
(meta-analysis)
(n = 9)

Figure 1.2. Flow diagram of study selection for integrative review (PRISMA).

The small number of RCTs that were eligible is owing to the challenge of segregating the
effects on older adults in studies with mixed populations of patients. This review included those
RCTs with older adult participants only. The intervention studies included patients who had
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completed adjuvant treatment and were with or without hormone therapy. The physical activity
interventions included aerobic exercise; resistance exercise; and impact training exercise under
direct supervision and/or home-based. Sample sizes ranged from 57-192 participants. All studies
were conducted in older adults with the average age of participants being 65 years old (SD= 8.1).
Review of Fatigue Measurements
All articles but one (Yeo et al., 2012) lacked theoretical definitions of fatigue, meaning
there was no consensus on operational definitions. Eight different measures were used to assess
the fatigue including the following:
The Functional Assessment of Cancer Therapy-Fatigue subscale (FACT-F).
The FACT-F was the fatigue measure used in Bourke et al., (2011a, 2011b) studies. It is a
measure of QOL in cancer treatment, derived from the FACT general form (Cella et al., 1993),
with more focus to the problems of fatigue. The fatigue subscale is a separate 13-item reliable
measure of fatigue that has been used in a number of fatigue intervention studies (Dhillon et al.,
2012; Giacalone et al., 2013; Pertl, Hevey, Collier, Lambe, & O’Dwyer, 2013; Si et al., 2012;
Yennurajalingam et al., 2016). FACT-F has a strong reliability (coefficient alpha range = 0.93–
0.95), and it showed a significant positive correlation with other measures of fatigue. Yellen,
Cella, Webster, Blendowski, and Kaplan, (1997) have been able to derive a change in scale
scores that correspond to minimum clinically significant differences which is especially useful
for intervention studies. Scores on this measure range from 6 (high fatigue) to 52 (low fatigue),
and it is considered a valid measure of the physical and functional effects of fatigue (Yellen et
al., 1997).
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The Fatigue Severity Scale (FSS).
The seven-point 9 item Fatigue Severity Scale utilized by Culos-Reed et al., (2010) was
originally validated in a non-cancer population (namely multiple sclerosis and systemic lupus
erythematosus patients). While it has been extensively used in chronic fatigue and neurological
disease, it has had very limited use in cancer patients (Stone, & Richards, 2001). The total score
for this measure is calculated by averaging the scores of each item resulting in scores that range
from 0 To 10 ( Minton & Stone, 2008). The greater the number, the worse the fatigue. CulosReed et al., (2010) defined severe fatigue as being a score of 4.5 or greater. However, this study
failed to demonstrate a significant change in FSS scores among the cancer patients in comparison
with two other fatigue measures that showed significant changes.
Fatigue subscale of the European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire C30 (EORTCQLQ-C30).
The EORTC QLQ C30, used by Galvão et. al, (2010), is a 30-item quality-of-life measure
which incorporates 9 multi-item scales: 5 functional scales (physical, emotional, social, role, and
cognitive); 3 symptom scales (pain, fatigue, nausea and vomiting); a global health and qualityof-life scale. It also includes several single-item symptom measures. The fatigue subscale has
three-items and has been independently validated as a separate fatigue measure. The items are
rated on a Likert-type scale from 1 (not at all) to 4 (very much), with a higher score on the
subscale indicating a greater fatigue severity. While this measure has weaker psychometric
properties than more extensive fatigue scales (Cronbach’s alpha = .80-.85, convergent validity
with other scales r = 0.49-75), it is short and easy to administer which may compensate for this
drawback. However, it has been reported to have a floor/ceiling effect in advanced cancer

26

patients and is not recommended as a single measure to measure fatigue (Paiva et al., 2014;
Minton & Stone, 2008; Aaronson et. al, 1993).
Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-F).
Hawkes et al. (2013) used the FACIT Fatigue scale, a self-report questionnaire that has
been validated for use with older adults. It is a short 13-item, easy to administer tool that
measures the level of fatigue on a four-point Likert-type scale (4 = not at all fatigued to 0 = very
much fatigued) during one’s usual daily activities over the past week. Scores may range from 0
to 52 with higher scores indicating less fatigue and better QOL (Cella et. al, 1993). The FACIT
Fatigue Scale is written at the 4th-grade reading level and takes 5-10 minutes to complete. A
score of < 30 indicates severe fatigue (Webster, Cella, & Yost, 2003). The FACIT-F scale has
demonstrated high internal consistency reliability (Cronbach’s alpha = 0.96, inter-item
correlation = 0.95). High correlation with other measures of fatigue (r = -79 with FSS) and
sensitivity to change in older adult patients with chronic health conditions support construct
validity (Chandran, Bhella, Schentag, & Gladman, 2007).
Chalder Fatigue Scale/Fatigue Questionnaire (FQ).
Oldervell et al., (2011) assessed fatigue using the Chalder Fatigue Scale that is also
known as the Fatigue Questionnaire (FQ) (Chalder et al., 1993). This is an 11-item
multidimensional scale that measures physical fatigue (PF), mental fatigue (MF), and total
fatigue (TF) on a 4-point Likert-type scale that was originally validated in the general
population, and its main use has been in the assessment of chronic fatigue syndrome. The FQ is
considered brief and easy to administer and score, with higher scores indicating more fatigue,
with acceptable psychometric properties across different populations; it has been recommended
for use in cancer patients (Minton & Stone, 2008).
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Revised Piper Fatigue Scale (PFS).
In the study by Wenzel et al. (2013) fatigue was measured by the revised Piper Fatigue
Scale (PFS) a 22-item10-point Likert-type self-report scale. The PFS is a comprehensive
instrument that measures total fatigue and four subjective dimensions of fatigue including
sensory, cognitive/mood, affective meaning, and behavioral/severity. The entire scale (22 items)
demonstrated high internal consistency reliability with Cronbach’s alpha = 0.97 (Piper et al.,
1998). While it has been validated in a group of breast cancer survivors, there are limited data on
the psychometric properties of the PFS modified version for use in other cancer population
(Minton & Stone, 2008).
Profile of Mood States (POMS) Fatigue Subscale.
The POMS scale was initially developed to evaluate changes in mental and psychological
state. The shortened version used by Wenzel et al., (2013) is composed of six emotional distress
subscales including fatigue, anxiety, depression, anger, vigor, and confusion. The POMS-F is a 7item fatigue/inertia subscale (score range 0–28); higher scores indicate more fatigue experienced
during the past seven days (Shacham, 1983). This measure has been reported to have adequate
internal consistency reliability (α > .80), and correlated with other fatigue measures, such as the
revised Piper Fatigue Scale (r = .75, P = .01), and the Functional Assessment of Cancer Therapy
fatigue subscale (r = −.74, P < .05) which supports it construct validity.
Schwartz Cancer Fatigue Scale.
Schwartz Cancer Fatigue Scale is a six-item was used by Smith et. al, (2016). This selfreport tool allows individuals to rate their tiredness, difficulty thinking, and feelings of being
overcome, worn out, and helpless. The highest score is 30 points, where a higher score indicates
a greater fatigue. This test has been shown to be valid and reliable. Preliminary construct validity
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was demonstrated by differences in fatigue between two groups of cancer therapy and by scores
on a visual analog scale of fatigue. Cronbach's alpha for the total scale was 0.96 and estimated to
be between 0.82 and 0.93 for the subscales for the population of patients with cancer (Schwartz,
1998).
Physical Activity Interventions
Of the eight studies that implemented an intervention for cancer fatigue, seven trials
found positive results of physical activity interventions for the improvement of fatigue in older
cancer patients. Intervention periods ranged from 8 weeks to 12 months and included: homebased aerobic exercise only program (Wenzel et al., 2013; Yeo et al., 2012), combination of
supervised and home-based aerobic/resistance exercise program with dietary advice (Bourke et
al., 2011a, 2011b), supervised and home-based aerobic and light resistance training (Culos-Reed
et al., 2010), supervised only aerobic and resistance exercise program (Galvão et al., 2010),
telephone-based multiple health behavior change education intervention (Hawkes et al., 2013),
and a supervised aerobic exercise only program (Oldervoll et al., 2011).
Non-supervised interventions.
Home-based aerobic exercise.
Two RCTs applied a structured home-based aerobic exercise intervention without
supervised sessions and were able to draw similar conclusions. Yeo et al., (2012) tested the
effects of the walking program Every Step Counts in a sample (N=102) of adults with pancreas
and periampullary cancer. Every Step Counts walking program intervention consisted of a
walking prescription based on the American College of Sports Medicine (ACSM) guidelines.
The exercise prescription for the intervention group included a brisk 20- to 30-minute walk, with
a 5-minute warm-up period, and followed by a 5-minute cool-down period for 5 days per week.
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Participants were randomized into intervention group (n =54, mean age= 66) or usual care
control group (n=48, mean age 67). Cancer-related fatigue was measured by FSS and the Fatigue
Visual Analog Scale at baseline, at 3 months (intervention completion), and at 6 months follow
up. Comparing pre-test post-test scores between groups, only patients in the intervention group
had significantly improved fatigue scores (p= 0.05) by both fatigue measures at the end of the
study.
Similarly, Wenzel et al., (2013) evaluated the impact of Every Step Counts walking
intervention during cancer treatment on fatigue, sleep quality, and emotional distress, in a sample
of patients with mixed types of cancer (N=126; Age M= 60.2, SD=10.6) randomized to exercise
(n=68) or usual care control (n=58) groups. Assessment of fatigue was made using the modified
PFS at baseline and at the end of intervention (5 to 35 weeks) depending on the chemotherapy
regimen. Participants who reported more aerobic exercise, regardless of group assignment, had
significantly lower fatigue scores: PFS total fatigue (P=.035) and POMS fatigue subscale
(P=.020). Greater participation in the aerobic exercise was associated with 11% less fatigue
(P=.001).
Telephone-based behavior modification.
Hawkes and colleagues (2013) examined the effect of a 6-month telephone-based
intervention focusing on health behavior change related to physical activity, weight management,
dietary habits, alcohol, and smoking. A sample of 410 colorectal cancer survivors was
randomized into two groups. The intervention group (n=205 Age M=65.9 years, SD= 10.8)
received a total of 11 health change telephone sessions, 10 delivered as twice-monthly sessions
for 5 months followed by a final telephone session 4 weeks later, to promote self- management
techniques and maintenance of behavioral improvements promotion. The control group (n=205,
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Age M= 67.8, SD= 9.2) received usual care. To promote physical activity in the intervention
group, participants were given a pedometer and encouraged to achieve 10,000 steps per day as
the recommended goal, no individualized exercise prescription was given; exercise intensity was
not reported. There were no significant group differences found at 6 or 12 months for cancerrelated fatigue.
Supervised interventions with the home-based component.
Aerobic and resistance exercise with behavior modification.
A combination of aerobic and resistance training programs under the supervision of an
experienced exercise physiologist can produce parallel results even without a home-based
component. Galvão et. al, (2010) compared the effect of a twice a week for 12 weeks exercise
intervention to usual care. In a sample of 57 men who received androgen suppression therapy for
treatment of prostate cancer, randomized into an exercise intervention group (n=29) with an
average age of 69.5 years (SD= 7.3), and a usual care control group (n=28; Age M= 70.1, SD=
7.3). The aerobic component of the training program was moderate to high intensity and included
15 to 20 minutes of cardiovascular exercises (cycling and walking/jogging) at 65% to 80%
maximum heart rate and perceived exertion at 11 to 13 (6 to 20-point, Borg scale). Significant
differences were found between the groups favoring the exercise intervention group in the
reduction of fatigue (P=.021), nausea, and dyspnea, as well as improvements in the role and
cognitive functioning (Galvão et al., 2010).
Culos-Reed and colleagues (2010) tested a 16-week exercise program designed to
promote physical activity in 100 prostate cancer survivors receiving androgen suppression
therapy. Participants were randomized into either the physical activity intervention group (n=53;
Age M= 67.2, SD= 8.8) or the one-year waitlist control group (n=47; Age M= 68.0, SD= 8.4).
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This program consisted of home-based and supervised group individualized sessions tailored to
participants’ ability. Aerobic exercises consisted of walking, stretching, and light resistance
exercises with the use of resistance bands and core strengthening work using training ball. The
weekly group sessions lasted one and one-half hours and included physical activities and
education followed by group discussions that focused on shared concerns such as exercise goals
setting and overcoming barriers. The authors reported a non-significant trend toward
improvement in average fatigue scores on the FSS measure, in favor of the intervention group
which did drop from 4.49 at pre-test to 4.15, while the control group scores stayed virtually
unchanged (4.50 at pre-test and 4.46 at post-test).
Bourke and collogues (2011a) tested a lifestyle intervention in cancer-related fatigue for
prostate and colorectal cancer patients. The intervention combined aerobic and resistance
exercises, dietary advice, and a behavioral modification strategy to help improve compliance.
Fifty sedentary men with advanced prostate cancer, average age= 72, range= 60 – 87 years, who
had been receiving androgen suppression therapy (AST) for at least 6 months were randomized
into 2 groups: a 12-week intense exercise program with dietary advice (n =25; Age M= 72.2,
SD= 7.7) or standard care (n = 25; Age M= 71.3, SD= 6.4). During the intervention period, men
attended supervised exercise sessions for 30 minutes aerobic and 2 to 4 sets of resistance training
(body weight resistance and free weights) twice weekly for the initial 6 weeks and then once
weekly for the following 6 weeks. Also, the participants were instructed to perform a homebased exercise such as brisk walking, cycling, or gym exercise for 30-minute at least one session
per week during the first 6 weeks and a minimum of 2 sessions per week for the following 6
weeks, using an exercise diary to record activity. Intervention participants were encouraged to
reach a total of 5 sessions per week of exercise. Results of this feasibility study indicated that a
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pragmatic lifestyle intervention can produce significant improvement in fatigue (P = 0.002),
exercise behavior (P < 0.001), aerobic exercise tolerance (P < 0.001), and muscle strength (P =
0.033) compared with standard care controls during AST treatment.
In another feasibility study of older colorectal cancer survivors cohort (N=18) with a
mean age of 69 years (range= 52–80 years) Bourke et al.’s (2011b) physical activity program
was able to evoke similar significant improvement in cancer related fatigue (P=.005), replicating
the same lifestyle intervention in Bourke et al., 2011a’ trial.
Finally, a two-arm randomized controlled trial by Oldervoll et al., (2011) aimed to
determine the efficacy of an exercise intervention for reducing fatigue and improve physical
performance. Two hundred and thirty-one palliative care patients were randomized to a physical
exercise group (n=121; Age M=62.6, SD= 11.3) or a usual care group (n=110; Age M= 62.2,
SD= 10.7). The exercise group attended supervised biweekly sessions for 8 weeks. Each session
consisted of 10 to 15-minute aerobic warm up, 30 minutes of strengthening and resistance
exercises, and 10-15 minutes stretching and relaxation. Fatigue Questionnaire scores at baseline
and 8 weeks showed no significant difference between-groups effect in physical fatigue (P= .20),
total fatigue (P=.12), or mental fatigue (P=.13).
Functional Status
To explore the relationship between physical activity, fatigue, and functional status, we
must understand the effect of physical activity on functional status. A single-blinded RCT aimed
to evaluate the effects of exercise on functional status, investigating the changes in pulmonary
function, muscular strength, total muscle mass and peak oxygen uptake (Edvardsen et al., 2015).
Shortly after lung cancer surgery, 61 older adults with lung cancer were randomized into highintensity endurance and strength training (n = 30, Age M= 64.4, SD= 9.3), compared with
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controls (n = 31; Age M= 65.9, SD= 8.5) who received standard postoperative care. The
intervention group attended exercise sessions at fitness centers near the patients’ homes. Each
session was 60 minutes. Participant attended three times a week for 20 weeks. The session
started 5–7 weeks after surgery. The session included 1 hours a week group exercise. The
sessions were monitored by highly qualified personal trainers and under physiotherapists’
supervision. The exercise was well tolerated. Test scores of the medical outcomes short form
health survey (SF36), showed a clinically significant improvement in physical health, functional
status and QOL in the intervention group compared with the controls.
Galvao et al. (2010) assessed functional performance as a primary outcome of their
exercise intervention. The maximal weight lifted one time (1-RM) was a measure for the
dynamic muscle strength (chest press, seated row, leg extension, and leg press). Using the
maximal number of repetitions performed at 70% of 1-RM (for the chest press and leg press
exercises) muscle endurance was measured. Several measures of functional performance were
used. Using electronic timing gates, the 6-meter usual and fast walk and repeated chair rise to
standing (5 times) were assessed, and the 400-meter walk assessed cardiovascular capacity.
Dynamic balance was assessed by the 6-meter backward walk the sensory organization test and
the Neurocom Smart Balance Master. Galvao and his colleagues (2010) reported significant
improvements, in the exercise group compared with control group, of all functional performance,
muscle strength, and balance measures. The resistance/aerobic exercise was also able to reverse
total body and regional lean mass loss.
The study of Wenzel et al., (2013) also assessed physical functioning and fitness for
secondary study outcomes, controlling for age, cancer treatments, and gender. Comparing
patients with prostate cancer to non-prostate cancer groups, this study reported improvements of
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peak maximal oxygen uptake (8%) in prostate cancer patients, compared to > 9% loss in the nonprostate cancer group. Findings for those participants who engaged in more aerobic exercise also
included significant improvement in self-reported physical function, compared to other
participants who were less physically active. Participants’ mental and psychological status was
also measured, the Profile of Mood States Scale (POMS) assessments revealed that participants
who exercised more had significantly less emotional distress than their less active counterparts.
The study of Yeo et al., (2012) measured performance ability using the Eastern
Cooperative Oncology Group (ECOG) performance status scale. Functional status was assessed
using the Short Form-36v2 health survey which addressed 8 functional domains (cognitive
functioning, family and marital functioning, sexual functioning, social support, sleep, health
distress, physical symptoms and psychological symptoms). The findings of this study were
consistent with previous reports, performance (ECOG) and functional status (Short Form-36v2)
improvements were evident in the intervention group compared to the control (usual care) group.
Improvements in functional status were distinct in the Physical Component Summary (PCS) and
the Mental Component Summary (MCS) in both the intervention and the control group,
however, those with higher baseline score of MCS, depression, and poor functional status
reported less depression, higher physical functioning scores, and had lower cancer stage by the
end of the study.
Comparably, Oldervoll et al., (2011) hypothesized that the exercise intervention would
improve participants’ physical performance. Physical functioning as an indicator of physical
performance was a secondary outcome of the exercise intervention. This study included several
measurements of performance, the Karnofsky performance status scale (KPS) was used as an
indicator of survival. Measures of physical performance included sit to stand test, an indirect
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measure of strength in the lower limbs, the grip strength test as a measure of general strength,
and the maximal step length test as an assessment of balance. Functional capacity was measured
using the Shuttle Walk Test (SWT).
These authors reported both clinically and statistically significant intervention effects,
between exercise and control groups, in all measures of functional capacity and physical
performance. In those who completed the exercise intervention, KPS was a significant indicator
of survival after controlling for age and gender. Physical performance as well as general wellbeing improved after 6 weeks, and physical functioning parameters significantly improved 8
weeks post exercise intervention. Of note, those who dropped out of the intervention lost to
follow up, and participants who were in the waitlist were the ones with significantly lower KPS
scores, lower mean scores of all functional capacity and performance tests at baseline, compared
to those who completed the exercise intervention. These findings further support the contribution
of physical exercise in physical function maintenance, for older adult patients with advanced and
progressive cancer disease (Oldervoll et al., 2011).
Finally, Culos-Reed et. al, (2010) also included assessments of physical functioning as a
secondary study outcome. Measures of functional and aerobic capacity included the 6-min walk
test, the handgrip strength test, and assessed flexibility using the modified sit and reach test. The
European Organization for the Research and Treatment of Cancer, Quality of Life Study Group
(EORTC QLQ C30) was included as a measure of physical function. While the study findings
revealed significant improvements in physical fitness indicators for the intervention group,
compared to the control group participants, the mean scores for the functional subscale decreased
slightly for both groups from baseline to end of the study. However, those changes did not reach
significance, the EORTC QLQ C30 physical function subscale was reported to have poor
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reliability, therefore the authors did not include it in the final analyses. In this study, participants’
mental and psychological status was also assessed as a secondary outcome. The Center for
Epidemiological Studies Depression scale scores revealed that participants in the exercise group
had a decrease in depression, compared to an increase in the control group depression from preintervention. Of note, the study had a high dropout rate (34%) before post-testing, of the 100
participants 66 did not complete assessments, in their discriminant function analysis dropout
participants were revealed to be older and had higher depression scores.
Discussion
The current review of cancer-related fatigue emphasizes the management of fatigue
among adult cancer patients age 65 and older during and after completing cancer treatment. For
patients with prostate cancer who are undergoing androgen suppression therapy, research
indicated that implementing moderate to high intensity aerobic and resistance exercise programs
to promote physical activity may result in improved functional status and lower fatigue during
treatment, in either combination of supervised and home-based sessions or supervised sessions
alone without home-based component (Culos-Reed et al., 2010; Galvão et al., 2010; Bourke et
al., 2011a, 2011b).
The quality of the studies included in the review was variable; only one of the reviewed
studies included a theoretical definition of fatigue and presented a conceptual framework (Yeo et
al., 2012). The period of physical activity intervention varied from study to study (8-weeks-6months), there were also inconsistencies in the duration of activity and frequency, which may
have affected fatigue outcomes differently. Few of the studies reviewed included information
about the potential participant who declined participation in the trial; thus, the study participants
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may have been motivated to receive treatment, and so they would be systematically different
than those people who refused to participate, limiting the generalizability of the results.
Only one study adhered to the recommendations of the ACSM (Wenzel et al., 2013).
According to ASCM adults should undertake a moderate-intensity physical activity for 30
minutes 5 times a week, or a minimum of 20 minutes vigorous-intensity aerobic physical activity
3 times a week (Garber et al., 2011). Much of physical activity interventions reviewed did not
follow these recommendations.
Only four studies identified fatigue as a primary outcome (Hawkes et al., 2013; Oldervoll
et al., 2011; Wenzel et al., 2013; Yeo et al., 2012). In the rest of the studies, fatigue was either
one of two or more secondary outcomes (Bourke et al., 2011a, 2011b) or reported and measured
as a QOL indicator or subscale (Culos-Reed et al., 2010; Galvão et al., 2010).
In comparison to supervised exercise sessions, structured home-based walking exercise
programs that adhere to the recommendations of safety, intensity and guidelines of ACSM
showed significant improvement of fatigue among older cancer patients with different types of
cancer diagnoses. Patients who participate more in home-based aerobic exercises with moderate
intensity such as brisk walking had significantly less fatigue (Yeo et al., 2012; Wenzel et al.,
2013). On the contrary, other randomized controlled trials did not have significant fatigue
reduction results, including one that did not incorporate an exercise prescription (Culos-Reed et
al., 2010), another one depended on telephone counseling alone (Hawkes et al., 2013), and the
last did not provide a structured physical activity intervention that adhered to the standards and
guidelines (Yeo et al., 2012). Incorporating physical activity interventions in cancer fatigue
symptom management can also be beneficial in improving functional status objectively (Bourke
et al., 2011a, 2011b). The improved measures included aerobic exercise tolerance, functional
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capacity and muscle strength for older adult cancer patients. Furthermore, the frailty associated
with older age, besides cancer patients’ disease and treatment, as well as the relative occasions of
inactivity associated with the cancer symptom experience disposes this population to a major risk
for falls and injury. Exercise-based interventions are able to modify this risk. Regular
participation in moderate to high-intensity exercise programs mitigate falls risk through
improvement of functional status: increasing muscle strength, muscle mass, improving gait
patterns and balance control (Galvão et al., 2010). Older adults with cancer can benefit from
different exercise modalities to target each of those areas of impairment selectively or in
combination (Sherrington et al., 2016).
Contributing factors of successful physical activity interventions must be taken into
consideration. The timing of physical activity interventions for patients during or after
completion of cancer treatment may evoke significant improvement in fatigue compared to
advanced stage or short life expectancy periods (Oldervoll et al., 2011). In 2017, a meta-analysis
of systematic reviews supported the evidence found in this review. In agreement with our
proposed research study, it acknowledged the significance of the challenge facing both cancer
population and clinicians (Stout, Baima, Swisher, Winters-Stone, & Welsh, 2017). The challenge
seems to be optimizing functional status and survival. Despite the growing and robust body of
evidence identified which supports the need to include exercise in most of the care plans of
patients with cancer, there is a lack of practice guidelines for older adult hospice patients.
In addition to the absence of practice guidelines for older adult hospice patients with
cancer, the lack of structure or precise prescription of physical activity hinders its effect on
fatigue (Hawkes et al., 2013). Equally important is adhering to ACSM guidelines when
constructing physical activity programs and maintaining adequate exercise intensity levels
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appropriate to the age and health status of the participants (Yeo et al., 2012; Wenzel et al., 2013).
The randomized controlled trials in this review demonstrated effectiveness of structured physical
activity interventions in reducing fatigue for older adult cancer patients with fatigue compared to
controls (Bourke et al., 2011a, 2011b; Culos-Reed et al., 2010; Galvão et al., 2010; Oldervoll et
al., 2011; Wenzel et al., 2013; Yeo et al., 2012).
There is also evidence that functional status and physical performance have a
considerable response to earlier interventions (Edvardsen et al., 2015;), with improvements in
physical health and QOL (Wenzel et al., 2013; Yeo et al., 2012; Oldervoll et al., 2011; Galvão et
al., 2010). Perhaps fatigue and other fatigue-related symptom management interventions for
older adults need further investigation to gauge timing, duration, and intensity to clarify dose
response for future research (Minton, Jo, & Jane, 2015).
The management of clustered symptoms such as fatigue-related symptom cluster should
aim at multimodal interventions, which are supported by evidence of improvements in selfreported physical and role functioning (Culos-Reed et al., 2010; Galvão et al., 2010). Yeo et al.
(2012) examined the participants’ symptoms profile for evidence of symptom clusters, the most
predominant fatigue-related cluster (fatigue, bodily pain, depression, weakness, and anxiety) was
identified, this was considered as a preliminary evidence of the existence of a fatigue-related
symptom cluster. Also, several studies measured other symptoms including pain, emotional
distress, and depression. Key findings of those studies correspond to a decrease in total
depressions scores (Culos-Reed et al., 2010; Yeo et al., 2012), significantly less emotional
distress, less pain in addition to less fatigue, physical functioning, and more vigor in patients who
exercised compared to those who were less active (Wenzel et al., 2013). Incorporating behavioral
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modification strategies, to promote compliance with physical activity programs, can help
improve fatigue and its clustered symptom outcomes in older adult cancer patients.
Future Implications for Research and Practice
This review offers evidence that physical activity is beneficial for fatigue management
and maintenance of functional status. Further research is warranted to determine the most
effective physical activity parameters for older adults with cancer including intensity level,
duration, and frequency of sessions and safety for frail older patients. Also needed is consensus
on the most appropriate fatigue outcome measure. Further work needs to include patients with
advanced disease and hospice populations as the majority of the studies included in this review
had participants undertaking cancer therapy during the study period. In addition, future research
needs to sufficiently power trials to detect changes in depression, a psychological distress
concurrent with fatigue. Future research should also consider strategies to promote self-efficacy
to exercise and boost adherence rates. There is a great opportunity to benefit from the increased
public use of smartphones and health-related apps, as well as the availability of global
positioning systems and physical activity trackers. While tracking exercise and adherence can
benefit from trend following and the social media wave of the public desire for approval, setting
up effective regimens that conform to the recommended guidelines is essential. This makes it
amenable for researchers to customize physical activities to evoke precise outcomes, such as
monitoring exercise dose-response, self-efficacy, and adherence. Future physical activity
applications should be tailored to older adult cancer populations. A significant improvement in
cancer symptoms, functional status, and QOL becomes readily attainable as people with cancer
become self-motivated to change.
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Limitations
There are few limitations to this systematic review, one limitation is that it does not
evaluate the methodological quality of the studies using a validated technique. Also, as this
article is a part of a dissertation requiring independent student work, this constitutes a
methodological limitation because two independent reviewers is the gold standard for validating
the systematic review flowchart. Inclusion criteria limited the additional evidence available in
the non-English literature, as well as excluding abstract-only articles when the full text was not
available for review.
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Table 1. Summary of Characteristics of the RCT Studies Findings
Authors,
Date of
Publication

Bourke et
al., 2011

Research
Design/
conceptual
framework,
model
RCT; 2
group
conceptual
framework
not
indicated.

Bourke et
al., 2011

RCT; 2
group
parallel
conceptual
framework
not
indicated.

Culos-Reed
et al., 2010

RCT; 2
groups,
waitlist
control
conceptual
framework
not
indicated.

Purpose

Sample
Characteristics

Measures

Findings

Limitations

To evaluate the
feasibility of a
lifestyle intervention
designed to improve
fatigue,
physical/functional
fitness, QoL.

N=50 prostate cancer
(PCA) on ADT: age 60
or older 25 randomized
to exercise/diet
intervention + 25 usual
care control group.

FACT-F at baseline,
12 weeks (end of
lifestyle intervention)
and 6 months in both
groups.

The high rate of
attrition at 6 months
(44%) increase the
possibility of
differential
selection bias.

To evaluate the
feasibility of a
lifestyle intervention
designed to improve
fatigue,
physical/functional
fitness, QoL, aerobic
exercise tolerance,
functional capacity,
muscle strength.
To investigate the
effects of physical
activity (PA)
intervention on PA
behavior, QOL, and
fitness measures.
Theoretical
framework not
indicated.

N=18 colorectal cancer
survivors 6 to 24m
post-surgery (mean age
69y) randomized to
(n=9) lifestyle
intervention or control
standard care (n=9).

FACT-F at baseline,
and at 12 weeks (end
of intervention).

Lifestyle group
improvements in exercise
behavior (P < 0.001),
aerobic exercise tolerance (P
< 0.001), and muscle
strength (P =0.033)
compared with standard
care. Significant fatigue
differences at 12 weeks
(p=0.002) in intervention
group compared with
control, at 6 months P =
0.006).
Lifestyle intervention had
significant improvements in
fatigue (P=.005, d=.52),
exercise behavior (P=.068),
aerobic exercise tolerance
(P=.010), functional
capacity (P=.003). No
change in QOL.

N=100 PCA survivors
receiving ADT
Mean age 67.6y.

FSS at baseline and
16 weeks (end of
intervention).
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Non-significant change in
scores (P>.05) However,
average fatigue scores for
the intervention group did
drop from 4.49 to 4.15, the
controls remained almost
unchanged (4.50 at pre-test
and 4.46 at post-test).

Small sample size.
Responses were
subject to recall
bias.

77.8% adherence,
34% drop out.
Low statistical
power.
Blinding not done.
Randomization
method not
described.

Table 1. (Continued)
Galvão et
al., 2010

RCT 2 group
parallel
design
conceptual
framework
not
indicated.

To compare he
effects of a 12-week
combined resistance and
low volume aerobic
exercise compared to
usual care on muscle
mass, strength, physical
function, enhanced
health status.

N=57 PCA patients,
randomized into
exercise group n=29
and usual care control
group n=28.

EORTC QLQC30

Significant differences between the
groups favoring exercise
intervention: reduction in fatigue
(P=.021), nausea, and dyspnea, and
improvements in role and cognitive
functioning.

EORTC QLQC30 is not a
valid measure
of Fatigue as an
endpoint.

Hawkes et
al., 2013

RCT, 2
group design
conceptual
framework
not
indicated.

To determine effects of
a 6 months telephone
behavioral intervention
on health outcomes
including PA, HRQoL,
fatigue, (BMI), diet, and
smoking.

N= 410, CRC
survivors randomized
to health coaching
intervention (n=205)
or usual care (n=205)

FACIT-F at
baseline, 6
months and 12
months

There were no significant
intervention effects at 6 or 12
months for mental HRQoL or
cancer-related fatigue

Participants
were not
blinded to study
condition.

Oldervoll et
al., 2011

RCT 2 group
design
conceptual
framework
not
indicated.
RCT 2 group
design
conceptual
framework
not
indicated.

Determine the efficacy
of an exercise
intervention for
reducing fatigue and
improve physical
performance.
Evaluate the impact of a
home-based walking
intervention during
cancer treatment on
sleep quality, emotional
distress, and fatigue.

N=231 palliative care
patients randomized to
physical exercise
group (n=121) or usual
care group (n=110).

Fatigue
Questionnaire
(FQ).

There is no significant betweengroups effect in physical fatigue
(P= .20), total fatigue (P=.12), or
mental fatigue (P=.13).

N=138 patients with
prostate (55.6%),
breast (32.5%), other
solid tumors (11.9%)
randomized to a homebased walking exercise
(n=68) or usual care
control (n=58).

Profile of Mood
States (POMS)
Fatigue
Subscale,
Modified piper
fatigue scale
(PFS) at baseline
and at end of
intervention (5 to
35 weeks).

Participants who reported more
aerobic exercise, regardless of
group assignment, had
significantly lower fatigue scores:
PFS total fatigue (p=.035) and
POMS fatigue subscale (p=.020)
greater participation in the aerobic
exercise was associated with 11%
less fatigue (p=.001).
Using intention to treat analysis the
PFS showed no significant
difference in fatigue between
groups (p=.46).

High drop-out
rate (35 %
intervention
group, 22%
usual care
controls).
Exercise crossover effect in
both groups,
32.4% of
participants
assigned to
exercise
“dropped out”
and 12% of
controls
“dropped in” to
exercise.
Lack of racial/
ethnic diversity.

Wenzel et
al., 2013
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Table 1. (Continued)
Yeo et al.,
2012

RCT 2 group
design,
conceptual
framework:
Levine
Conservation
of Energy
Theory.

Examine the effects
of a walking program
on CRF, physical
functioning, QOL,
and to explore
symptom burden and
clustering.

N=100 pancreas/
periampullary cancer
patients n =50
intervention and n=50
usual care control
groups.

Fatigue severity scale
(FSS) and fatigue
Visual Analog Scale
at baseline and at 3 to
6 months.

Comparing pre-test post-test
scores between groups, only
patients in the intervention
group had significantly
improved fatigue scores by
both fatigue measures at the
end of the study, as compared
with their own baseline (p=
0.05).

Edvardsen
et al., 2015

RCT 2 group
single
blinded
design,
conceptual
framework
not
indicated.

Evaluate the effects of
high-intensity
endurance and
strength training on
change in peak
oxygen uptake from
baseline to after
intervention. Explore
changes in pulmonary
function, muscular
strength, total muscle
mass, daily physical
functioning, and
QOL.

N= 61 Lung cancer
patients after lung
cancer surgery, n= 30
intervention, n= 31
usual care control
group.

SF-36, EORTC QOLC30, and a battery of
physical functioning
tests before surgery,
4–6 weeks after
surgery and
immediately after the
intervention.

High-intensity endurance and
strength training
is well tolerated and
significantly improves
cardiorespiratory fitness,
muscular strength, daily
physical functioning, total
muscle mass and quality of life.

Lack of
racial/ethnic
diversity
primarily white
sample well
educated
The sample was
motivated to
receive
treatment,
limiting the
generalizability
of the results.
Low response
rate to the QOL
questionnaires.
technicians
were possibly
not blinded
during the last
data collection.

*RCT-Randomized Controlled Trial, QOL-Quality of Life, ADT-Androgen Deprivation Therapy, FACT-F- Functional Assessment of Cancer Therapy-Fatigue, FSS- The Fatigue
Severity Scale, EORTC QOL-C30- European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30, Fatigue subscale, HRCOL-Health-Related
Quality of Life, BMI-Body Mass Index. POMS- Profile of Mood States Fatigue Subscale.
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Section Two: Validity and Reliability of the Center for Epidemiologic Studies Depression,
Boston Short Form: A Clinically Relevant Scale for Depression Detection in Cancer
Patients
Abstract
The purpose of this study was to investigate the reliability and validity of the Center for
Epidemiology Studies-Depression scale, Boston Short Form (CESD-10), as a clinically relevant
depression measure used for cancer center outpatients. A secondary data analysis from a larger
study was conducted. Using Structural Equation Modeling (SEM) for confirmatory factor
analysis, the factor structure of responses in a cross-sectional sample (n = 200) was examined.
Internal consistency of the instrument was estimated using Cronbach’s alpha. The factor analysis
demonstrated that the CESD-10 contains the same underlying factors of positive affect,
depressive affect, somatic complaints, and interpersonal challenges found in the full CES-D; the
four-factor depression model fits the data well. Internal consistency reliability coefficient was
satisfactory (Cronbach’s alpha = 0.737). The CESD-10 is a valid and reliable measure for
assessing depressive symptoms among patients with cancer who are participating in a research
study. Using this simple and brief scale in clinical settings can help clinicians detect depression
in older adults with cancer.
Keywords: cancer, depression, oncology, psychological assessment, psychometrics, structural
modeling.
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Note to Reader
Portions of this chapter have been submitted for publication and are currently under the
review of The Journal of Psycho Oncology.

Introduction
Depressive symptoms are highly prevalent among cancer population (Massie, LloydWilliams, Irving, & Miller, 2011). A diagnosis of cancer can be mostly sad and traumatic,
however, when it’s said to be terminal it sets the person who receives it for a greater sense of loss
and pervasive hopelessness. There are so many losses which people with cancer face; the loss of
health, wealth, self-image, and the sense of control are initially experienced early on along the
cancer continuum. These psychological symptoms always present in a physiological number of
symptoms that interfere with the individual’s quality of life and are associated with a significant
decline in performance status and functional ability, as well as a reduction in the utilization of
health care and treatment adherence. Depressive symptoms have been measured in research
using a variety of scales. The Center for Epidemiologic Studies-Depression (CES-D) scale has
been extensively used as a self-administered screening tool for identifying depressive symptoms,
both in clinical and research settings (Comstock & Helsing, 1976; Radloff,1977; Radloff &
Lock, 1986; Nezu, A., Nezu, C., McClure, & Zwick, 2002; Murphy, 2002; Eaton, Muntaner,
Smith, Tien, & Ybarra, 2004). Even though the full 20-item CES-D remains one of the most
widely used instruments in the field of psychology, its length impedes its use in a variety of
clinical settings, especially among vulnerable populations. This has led to the development of a
shorter version, the Center for Epidemiologic Studies-Depression-Boston Short Form, also
known as CESD-10 scale. This adapted scale balances respondent burden and psychometric
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integrity. Radloff originally reported that the 20 items of the scales could be summarized into
four factors: positive affect, depressed affect, interpersonal challenges, and somatic complaints.
Mogos et al. (2015) have recently confirmed the longitudinal invariance of the four-factor
structure. The factor structure of the CESD-10 has been debated in the literature (Amtmann et
al., 2014; Carpenter et al., 1998; Kohout et al., 1993). Although the four-factor structure had
been replicated in other studies (Irwin, Artin, & Oxmnan, 1999; Kohout et al., 1993), its
structural validity has not been verified in the people with all types of cancer. The 10 items that
were retained from the original CES-D scale for the CESD-10 are shown in Table 1.1.
It is generally acknowledged that symptoms of depression exist in patients with cancer.
Understanding depression in cancer patients calls for understanding measurement of its
symptoms. While self-report assessment measures can never adequately diagnose a psychiatric
disorder without a complete clinical assessment, they can help identify depression symptoms
provided that these measures demonstrate acceptable reliability and validity. It is important to
examine the CESD-10 for evidence of reliability using Cronbach’s alpha coefficient, and for
evidence of construct validity. Using structural equation modeling (SEM) to conduct
confirmatory factor analysis this study aimed to: examine the factor structure of CESD-10 for
evidence of validity, and reliability. It was hypothesized that CESD-10 would be a reliable scale
that exhibits the same symptom dimensions found in the original 20-item CES-D, supporting
construct validity.
Method
Sample.
The initial sample consisted of 201 adults with cancer who were enrolled in a large
Patient-Centered Outcomes Research Institute (PCORI) funded clinical trial (CE-12-11-4025).
Participants were outpatients recruited at a large and comprehensive National Cancer Institute52

designated center in southwest Florida. They were included in the parent study if they had
baseline scores of a cancer symptom intensity, distress, and/or interference ≥ 4 for at least 2
symptoms on the Cancer Symptoms Scale (McMillan, Tofthagen, Choe, & Rheingans, 2015).
The participants had to be 18 years old or older, were fluent and literate in the English language,
had passed mental and functional status screenings, and were near the beginning of their therapy
for cancer (at least 3 chemotherapy cycles or three weeks of radiation therapy remaining for
treatment). Only participants who consented to participate in the parent study and completed
CESD-10 assessments were included in this secondary baseline data analysis. Individuals who
were within six weeks following surgery, planned to leave Florida during the intervention, were
in hospice care, confused, or were expected to die within 3 months were excluded from
participation.
Measures.
Following approval by the university’s Institutional Review Board, the CESD-10 was
administered as part of a larger battery of instruments used in the clinical trial (CE-12-11-4025).
The demographic data were collected from electronic health records.
Center for Epidemiology Studies-Depression, Boston Short Form (CESD-10). This 10item depression screening tool has been widely used in research. However, it should be noted
that it is not a diagnostic tool, but rather a symptom assessment scale with only 10 items and
yes/no answers. It combines ease of administration and reduced questionnaire burden with only 2
minutes’ administration time. It has been utilized in cancer research, in samples of patients with
breast cancer (Carpenter et al., 1998; Hann, Winter, & Jacobsen, 1999; Stagl, et. al, 2015), and
elderly hospice cancer patients (Garrison, Overcash, & McMillan, 2011), but this is the first
validation study of CESD-10 in a sample of patients that included all types of cancers and both
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sexes. This short version was developed in the multi-site research project led by Kohout et al.
(1993). The 10 items that were selected for the short form were based on the original scale factor
analysis; these items had high correlations with the 20 items of the widely validated full scale
(Cronbach’s alpha = .88) and had a similar pattern of loadings to the four dimensions reported by
Radloff (1977) depressed affect, positive affect, somatic complaints, and interpersonal
challenges.
Kohout et al. (1993) reported that shortening the scale did not compromise its reliability
(Cronbach’s alpha = 0.80 versus 0.86), and the total proportion of the variance in all 10 variables
explained by the four factors was 66%. The value of variance explained along with the similar
pattern of loadings indicates that the short form strikes the same symptom dimensions of
depression found in the original CES-D.
In the shortened form, the items are coded dichotomously as present or absent, rather than
the frequency rating in the full CES-D where scores ranged from 0 to 20. Total scores of the
shortened scale range from 0 to 10. Simplifying the response options to “yes” or “no” had
demonstrated convenience for use among patients who may find the questions of the scale
emotionally distressing. This approach also reduced respondents’ confusion associated with
scoring responses on the Likert-type scales (Irwin et. al, 1999). Using a sample of clinically
diagnosed middle-aged individuals with major depression as a criterion standard (n = 40) and
healthy comparison controls (n = 43) who had no lifetime history of psychiatric diagnosis and
were never mentally ill, Irwin and colleagues (1999) set the cutoff score to 4 to detect
depression in those depressed patients, a low cutoff score that is consistent with the screening
purpose of CESD-10. Of the 40 depressed patients, 39 were positively identified and one was a
false negative, using this cutoff score yielded a high sensitivity of 97%, specificity of 93%, and a
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predictive value of 85%. Both internal consistency (Cronbach’s alpha = .92) and test-retest
reliability with 3 to 4 weeks’ delay (r = .83) were reported to be very strong (Irwin et. al, 1999).
Procedures.
The present study proposal was approved by the University of South Florida Institutional
Review Board. For this secondary data analyses of the CESD-10, de-identified data were
obtained from the principal investigator. Data were examined for outliers and missing data.
Data analysis.
SPSS software version 24.0 was used to describe sample characteristics, compute
depression scores, and conduct reliability analyses. A minimum of 0.70 for Cronbach’s alpha
reliability coefficient was used to indicate the internal consistency of the scale. To assess the
construct validity of CESD-10, the statistical software package LISREL 9.2 (Jöreskog &
Sörbom, 2015) was used to conduct confirmatory factor analysis (CFA). To evaluate the CFA
models, we relied on several measures of fit: Root Mean Square Error of Approximation
(RMSEA), Standardized Root Mean Square Residual (SRMR), Adjusted Goodness of Fit Index
(AGFI), Goodness of Fit Index (GFI), and Comparative Fit Index (CFI). Since 1999, Hu and
Bentler conducted extensive simulation studies on covariance structure analysis (Hu & Bentler,
1999). These investigators reported that some of the conventional cutoff criteria for those fit
indices tend to overly reject true‐population models, especially for small size samples. It is
suggested that a relatively good-fitting model will have RMSEA cutoff values close to .06,
SRMR cutoff values close to .08, CFI cutoff value close to .95, GFI and AGFI cutoff values
close to .90 (Bentler, 2007).
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Results
Sample demographics and clinical characteristics.
One case was excluded due to a missing CESD-10 item response, leaving 200 cases for
analysis. Demographic and clinical characteristics are summarized in Table 1.2. The sample
accrued for this analysis included 200 patients with a wide variety of cancers including 25%
diagnosed with breast cancer, 7% with colon cancer, 6.5% with ovarian cancer, and 6.5% lung
cancer, as well as other types of cancer. The mean age of the participants in this sample was
approximately 58 years old (SD=12.2); there were 76 males and 125 females. Of the total
participants, 61.2% reported being married, 62% were females, and had an average education of
14.9 years. The sample was predominantly White/non-Hispanic (83.6%); the remainder of the
sample self-identified as Black/non-Hispanic (9.5%), White/Hispanic (4%), and
other/nondisclosed (2%). The mean CESD-10 score was 2.57, with a standard deviation of 2.2
(Table 1.2). Overall, 29.5% of the participants reported total scores on CESD-10 to be  4, which
is indicative of a certain degree of depression. More women (64.4%) than men (35.6%) in the
sample reached the cutoff score for depression.
Reliability.
Reliability analysis was conducted using SPSS reliability procedure. The correlation
matrix, presented in Table 1.3, shows that the average inter-item correlation was .233. Item-total
correlations are shown in Table 1.4. The item-total correlations ranged between .205 and .570.
Using Cronbach’s coefficient of internal consistency, the overall reliability coefficient for the
scale scores in this sample was .737.
Validity.
Prior to conducting the analysis, the data were examined for their suitability for analysis.
First, the average inter-item correlation within the scale was .233. Second, the determinant of the
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correlation matrix approached zero (.060) and the Kaiser-Meyer-Olkin Index of Sampling
Adequacy was .691, which is above the recommended value of .60. Finally, the Bartlett's Test of
Sphericity was significant (2 = 546.75, df = 45, p < .001). Based on these criteria, the inter-item
correlation matrix was deemed adequate for factor analysis.
Confirmatory factor analyses were conducted to compare two models, a simple onefactor model to evaluate unidimensionality of the CESD-10 scale, and a second model, a fourfactor theory-driven model based on the work of Irwin et al. (1999), Kohout et al. (1993), and
Radloff (1977). The models were specified to include Lambda-X, Phi, and Theta-Delta matrices,
and both models were fit to the data. The goodness of fit indices of the single factor model (2 =
265.057, df = 35) were not within an acceptable range (RMSEA = 0.181, GFI = 0.791, CFI =
0.554, SRMR = 0.114, and AGFI = 0.672).
The theory-driven four-factor model, including depressed affect (DA), positive affect
(PA), somatic complaints (SC), and interpersonal challenges (IP), was also fitted to the data (2 =
37.012, df = 29). A formal test comparing the two models was conducted by comparing this Chisquare with that of the one-factor model. The change in comparison was significant (2 =
227.988, df = 6, p < .001). The four-factor model fits the data significantly better than the single
factor model. Improvements in the other indices of fit are shown in Table 1.5. The parameter
estimates from the four-factor model are shown in Table 1.6. All of the factor loadings were
statistically significant. Standardized factor loadings were ranging from .237 to .883. Item 3
(‘restless sleep’) had the lowest loading and item 7 (people unfriendly) had the highest loading.
The pattern of each factor loadings was as follows: Depressed Affect (Items 5, 6, 8), Positive
Affect (Items 1, 4), Somatic Complaints (Items 2, 3, 10), and Interpersonal Challenges (Items 7,
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9). The highest factor correlation was between the interpersonal challenges and somatic
complaints factors (r = .634), and all factor correlations were modest in size (Table 1.6).
Discussion
Reliability.
The present study examined the reliability and factorial structure of the CESD-10 scale in
a mixed sample of patients with cancer. Reliability of the data was assessed by Cronbach's alpha
coefficient prior to testing the measurement structure of the CESD-10 scale. The coefficient was
satisfactory (Cronbach’s alpha = 0.737) for the overall sample; while this is an acceptable value
of reliability, it is considered relatively low compared to what was reported by earlier authors
(Kohout et al., 1993).
To examine this relatively low-reliability coefficient, we considered various aspects,
including scale attributes or items specific factors such as low inter-item correlations, a small
number of items, or heterogeneous constructs (Cortina, 1993), and possible reliability measure
limitations. Cutting the length of the CES-D from the original 20 items to the Boston Short form
might be expected to decrease the value of Cronbach’s alpha (Tavakol & Dennick, 2011).
Particularly in the context of internal consistency, consideration must be given to the source of
error related to the assumption of homogeneity of the scale items. A set of scale items is said to
be homogeneous when they measure to some degree the same concept on a unidimensional
scale. Both the magnitude of inter-item correlations as well as the number of items in the scale
also have an influence on homogeneity and the value of Cronbach’s alpha (Tavakol & Dennick,
2011).
In other words, symptom measurement scales usually involve multiple items, each item
is an indicator of the same attribute or symptom of a construct (e.g., depression). When using the
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CESD-10 with the intention to measure attributes of depression, clinicians and researchers are
measuring co-occurring, unique, interrelated, and possibly exchangeable symptoms. Through
calculating a total score from the unweighted sum of item scores, the attribute levels can be
identified. Researchers suggest that computing a total or composite score from a set of scale
items would only be meaningful if all the scale items were unidimensional (Widhiarso &
Ravand, 2014). In our sample, an inspection of the scale dimensionality reveals that the items
have low intercorrelations, despite the theoretical supposition that these 10 items assess the same
construct. In this case, the assumption of multidimensionality holds, and the literature suggests
that using a unidimensional reliability measure such as Cronbach’s alpha coefficient would have
limited application in such situations (Green & Yang, 2009; Widhiarso and Ravand, 2014).
However, the 10 items of the CESD-10 provide a measure of depression using different
indicators, including depressed affect, the lack of positive mood, somatic complaints, and social
or interpersonal challenges. The heterogeneity of the constructs in this scale can potentially
contribute to underestimating its internal consistency using the Cronbach’s alpha reliability
coefficient. Retaining the somatic complaints and interpersonal challenges items in the shortened
CESD-10 was done specifically by the scale developers to preserve the original scale factorial
structure (Kohout et al., 1993) capturing the multidimensions of depression symptoms.
Construct validity.
Confirmatory factor analysis was used to assess the construct validity of the single factor
and four-factor structures of the scale that are hypothesized in the literature. In general, the
results indicate that the single-factor structure was far from fitting the data adequately. The fourfactor model proposed by Kohout et al. (1993) was a better fit for the present study’s data. In
another study, Irwin et. al, (1999) demonstrated that a four-factor structure of CESD-10 was
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valid for screening for major depression in older adults. Their results replicate the four-factor
solution originally proposed by Radloff (1977) with only minor differences in factor loading
patterns on the four CESD-10 subscales.
The four factors found in this sample of cancer patients are consistent with the
components of depression built in the original CES-D scale. It is important to note that all 10
items of the scale are indicators of symptoms or moods of depression; although they are related
to each other, their dimensions are unique. However, despite the focus of theory and empirical
evidence on the orthogonal four factors, the literature does not imply an undue emphasis on
separate factors or subscales. In presence of high internal consistency and Cronbach’s alpha
values, a simple total CESD-10 score should always be considered as an estimate of depression
symptoms.
The present findings generated in a sample of both men and women with a variety of
types of cancer show that the abbreviated version of the CES-D has a reliability and validity
comparable to that reported for the original 20-item scale (Kohout et al., 1993). The mean scores
on the CESD-10 were relatively low, but almost 30% of patients reported scores above 4 on the
CESD-10 indicating that they had depression symptoms that needed to be reported. The sample’
mean age was approximately 58 years old; collectively 38.8% of which reported being single,
divorced or widowed, and the majority were females. All of these are factors that may be
important to explore in future studies to evaluate independent contributions to these depression
scores.
Implications for Practice
Cancer patients who are in treatment may experience distressing physical symptoms such
as fatigue, nausea or pain that may render them unwilling to complete long questionnaires. The
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CESD-10 is a brief and easy-to-use tool to assess depressive symptoms. If patients report
symptoms of depression, oncology providers may need to refer them for further assessment by
mental health providers. It is common practice to ask patients about symptoms when they are in
the clinical setting. This secondary data analysis confirmed the importance of asking patients
about depressive symptoms when assessing other symptoms in clinical settings. The CESD-10
represents a valid and reliable means of measuring depressive symptoms in a vulnerable
population in which respondent burden to longer instruments is a key concern.
Implications for Research
If symptom assessment measures are found to be multidimensional, researchers should
consider applying alternative reliability coefficients. The appropriate coefficient to choose
depends on the study design, the construct being measured, and the data analysis method used in
the study. For example, studies that use structural equation modeling methodology for data
analysis should employ reliability coefficients based on the results of the confirmatory factor
analysis. Nonetheless, findings of this secondary analysis were limited by applying a single
measure for the assessment of reliability. Perhaps applying alternative methods of reliability
assessment in concurrence with Cronbach’ alpha should be explored in future research.
Summary
In conclusion, this study suggests that a four-factor CESD-10 depression model fits the
data well. The factor analysis demonstrated that the CESD-10 contains the same underlying
factors of positive and depressed affect, interpersonal challenges, and somatic complaints, all of
which were reported by the developer of the original 20-item CES-D (Radloff, 1977). To our
knowledge, this is the first report of construct validity using SEM factor analysis of the CESD-10
among cancer patients. Data collected using the CESD-10 appears both reliable and valid among
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patients with cancer who were in active treatment for their cancers. Using the short form is
warranted in situations where the desire to maintain psychometric properties is paired with a
need to reduce the respondent burden for vulnerable populations.
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Table 1.1 Full CES-D Items vs Boston Short Form.
Boston Short
Form 10 items

Standard CES-D twenty items
1. I was bothered by things that usually don’t bother me.
2. I did not feel like eating; my appetite was poor.
3. I felt that I could not shake off the blues.
4. I felt that I was just as good as other people.
5. I had trouble keeping my mind on what I was doing.
6. I felt depressed.
7. I felt that everything I did was an effort.
8. I felt hopeful about the future.
9. I thought my life had been a failure.
10. I felt fearful.
11. My sleep was restless.
12. I was happy.
13. I talked less than usual.
14. I felt lonely.
15. People were unfriendly.
16. I enjoyed life.
17. I had crying spells.
18. I felt sad.
19. I felt that people disliked me.
20. I could not "get going."

__
__
__
__
__
x
x
__
__
__
x
x
__
x
x
x
__
x
x
x

Intended factor

DA
SC

SC
PA
DA
IP
PA
DA
IP
SC

*IP = Interpersonal Challenges, DA = Depressive Affect, PA = Positive Affect, SV = Somatic
Complaints. Items included in the Boston Short Form indicated by x.
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Table 1.2 Sample Characteristics.
Characteristic

Over-all sample N=201

Age (years), mean (SD)

57.95 (12.2)

Gender n (%)
Male

76 (38)

Female

125 (62)

Education (years), mean (SD)

14.9 (2.6)

Ethnicity n (%)
White/non-Hispanic

168 (83.6)

White/Hispanic

8 (4)

Black/non-Hispanic

19 (9.5)

Other

4 (2)

Marital status n (%)
Single

27 (13.4)

Married

123 (61.2)

Divorced

36 (17.9)

Widowed

15 (7.5)

CESD-10, mean (SD)

2.57 (2.2)

Total score  4, n (%)

59 (29.5)

Male

21 (35.6)

Female

38 (64.4)

*SPMSQ = Short Portable Mental Status Questionnaire, CESD-10 = Center for Epidemiologic StudiesDepression (Boston Short form)
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Table 1.3 Correlation Matrix, Means, and Standard Deviations of Item Scores.
Depressive Symptoms
Enjoyed life

CESD1

CESD2

CESD3

CESD4

CESD5

CESD6

CESD7

CESD8

CESD9

CESD10

1

Everything was effort

.297

1

Sleep was restless

.158

.125

1

Happy

.659

.319

.194

1

Lonely

.186

.141

.092

.277

1

Depressed

.281

.234

.208

.263

.517

1

People unfriendly

.206

.040

.061

.253

.196

.157

1

Sad

.260

.232

.102

.324

.419

.661

.131

1

People disliked me

.153

.120

.043

.209

.223

.124

.655

.042

1

Couldn't get going

.274

.375

.062

.307

.169

.211

.177

.133

.208

1

Means

.145

.405

.605

.165

.225

.280

.040

.325

.035

.340

Standard deviations

.353

.492

.490

.372

.419

.450

.196

.470

.184

.475

* all correlations were significant at the 0.01-0.05 level (2-tailed)
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Table 1.4 CESD-10 Reliability Analysis Statistics.
Corrected Item-Total
Correlation
.494

Squared Multiple
Correlation
.459

Everything was effort

.389

.228

Sleep was restless

.204

.075

Happy

.559

.508

Lonely

.438

.321

Depressed

.570

.542

People unfriendly

.296

.460

Sad

.488

.484

People disliked me

.283

.461

Couldn't get going

.366

.213

Enjoyed life

Scale Mean
Scale Standard deviations

2.57
2.207

*CESD-10= Center for Epidemiologic Studies-Depression (Boston Short form)
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Table 1.5 Summary of Competing Model Fit Statistics for the CESD-10.
χ2

df

RMSEA

SRMR

AGFI

GFI

CFI

1.1 One factor model

265.0

35

0.181

0.114

0.672

0.791

0.554

1.2 Four-factor model

37.012

29

0.0372

0.0422

0.934

0.965

0.984

Model

*2 = Chi-square, df = Degrees of Freedom, RMSEA = Root Mean Square Error of Approximation,
SRMR = Standardized Root Mean Square Residual, AGFI = Adjusted Goodness of Fit Index, GFI =
Goodness of Fit Index, CFI = Comparative Fit Index.
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Table 1.6 Standardized Loadings and Factor Correlations for the CESD-10.
Indicator variable

Latent factor loading

Item
CESD1

Label
Enjoyed life

PA
.766

DA
-

IP
-

SC
-

CESD4

Happy

.859

-

-

-

CESD6

Depressed

-

.873

-

-

CESD8

Sad

-

.753

-

-

CESD5

Lonely

-

.588

-

-

CESD7

People unfriendly

-

-

.883

-

CESD9

People disliked me

-

-

.742

-

CESD2

Everything was effort

-

-

-

.616

CESD3

Sleep was restless

-

-

-

.237

CESD10

Couldn't get going

-

-

-

.570

Factor Correlations
IP

DA

PA

IP

1.000

DA

.416

1.000

PA

.319

.213

1.000

SC

.634

.450

.240

SC

1.000

* IP = Interpersonal Challenges, DA = Depressive Affect, PA = Positive Affect, SV = Somatic
Complaints.
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Section Three: Fatigue-Related Symptom Clusters and Functional Status of Older Adults
in Hospice
Abstract
Symptom control and improving quality of life (QOL) are important components of
comprehensive hospice care where palliation is the goal. Patients with advanced cancer
experience frequently complex and distressing co-occurring symptoms which affects their
functional ability and functional status. Fatigue in cancer remains one of the most prevalent,
persistent, and distressing symptoms experienced by this population. Although highly prevalent,
the relationship of fatigue symptom cluster on functional status remains inconclusive among
hospice patients. Fatigue-related symptoms experienced by hospice patients were examined.
Physical and psychological symptoms that co-occur together were explored, and the identified
cluster was used to discover predictors of functional status. The current study was conducted as a
secondary analysis of data from a hospice outcomes improvement initiative.
Findings will be discussed with respect to sample characteristics and results of cluster
and regression analysis. These data may contribute to a better understanding of fatigue symptom
cluster as predictors of functional status, also it could identify benefits of symptom cluster
assessment in patients with advanced cancer in hospice. This study will inform clinical practice
of innovative ways of utilizing systematic assessment for detection of functional outcomes which
can ultimately improve the QOL of patients who receive hospice services.
Keywords lack energy, physical activity, functionality, symptom co-occurrence, elders.
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Introduction
Symptom cluster refers to the presence of a group of related co-occurring symptoms
which can have an adverse effect on patient’ outcomes and may also have a combined effect as a
predictor of patient’s morbidity (Miaskowski, Aouizerat, Dodd, & Cooper, 2007; Nugent, 2013).
Patients in hospice care who were treated with surgery, radiation or chemotherapy, often
experience multiple symptoms that occur simultaneously (Kirkova et. al, 2010). Depression,
sleep disturbances, pain, poor appetite and difficulty of concentration are all symptoms that often
occur cluster with fatigue (Tsai, Wu, Chiu, & Chen, 2010; Dong, Butow, Costa, Lovell, & Agar,
2014; Nieder & Kämpe, 2017). Current interventions that manage fatigue symptom in cancer
patients only focus on fatigue as the single symptom outcome. Therefore, there is a need to
understand fatigue-related symptom cluster in order to improve future designs of fatigue
intervention research.
More than 1.7 million of the cancer population receive hospice services each year. It is
estimated that 83.3% of Medicare hospice patients are 65 years of age or older. Even with new
advancements in the treatment of cancer, it continues to be the number 1 diagnosis in hospice
admissions, accounting for 27.2%. The vast majority (97%) of hospice care is received as a
routine home care (National Hospice and Palliative Care Organization (2017). On average,
patients with a primary diagnosis of cancer receives 47 days (median 19) of health care under
hospices services, and close to 85% of the discharges are reported “deceased”. From these
estimates, it is understandable that older adults in hospice services with cancer are admitted near
the end of life, perhaps in late stages of their illness.
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They frequently experience a complex of distressing and co-occurring symptoms, as well
as higher levels of fatigue than their younger counterparts (Butt et al., 2010). Symptom
management is one of the most crucial components in their comprehensive hospice care.
The fatigue research in the cancer symptoms science has not been a focus in the older
adult’ population. There is a pressing need to investigate fatigue-related symptom cluster, as it
may be associated with a decline in functional status among older adult hospice patients (Esper,
2010; Cheng & Lee, 2011; Lengacher et al., 2012; Thomas et al., 2013; Dong et. al. 2014; Reich
et al., 2017). The treatment-limiting frailty and other age-related concerns such as slowed
metabolism, and multi-morbidities keep these patients from participating in research studies and
subject them to experience a rapidly progressive course of illness and increased disability (Butt
et al., 2010). Hence, there are detrimental effects on their well-being, mortality, and survival
(Beck, Towsley, Caserta, Lindau, & Dudley 2009; Costarella, Monteleone, Steindler, & Zuccaro,
2010; Payette et al., 2011). Additional studies are needed to delineate the fatigue-related
symptom cluster and its relationship with functional status among older adult hospice patients
with cancer. Fatigue has been considered a physical symptom due to complaints of physical lack
of energy (Kim, Puymon, Qin, Guru, & Mohler, 2014). Its relationship with psychological
distress, such as depression, is supported in the previous literature (Francoeur, 2014). There is a
necessity to control for depression when one investigates the relationship of fatigue-related
symptom clusters with functional status.
Research Aims and Hypotheses
This was a secondary data analysis study from a randomized clinical trial (RCT)
Symptom Assessment to Improve Hospice Outcomes funded by the National Institute of Health
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(McMillan, R01/5R01NR008252) of a sample of adult hospice patients (N=709). The following
aims and hypotheses were tested:
Aim 1. To explore the relationships between symptoms and identify fatigue-related symptom
clusters in older adult hospice patients.
Hypothesis 1. Older adult patients in hospice care experience multiple correlated
symptoms that cluster with fatigue.
Aim 2. To which extent fatigue-related symptom clusters predict functional status while
controlling for depression.
Hypothesis 2. Fatigue-related symptom clusters significantly predict functional status
while controlling for depression.
Method
The parent study description.
The parent study used a multisite, randomized controlled trial design, where interested
patient and caregiver dyads who were receiving hospice home care received standardized
symptom assessment. Two equivalent research teams were identified in each hospice service
involved in the study, and patients were recruited by these teams. The sample population was
patients and their caregivers in two hospices in Southwest Florida. The hospices provided
services to an average of 475 patients per day, who resided in a predominantly white with urban,
suburban, and rural areas. Approximately 25% of the deaths in these counties are due to cancer.
The largest proportion of the hospice patients have a cancer diagnosis (50%). Interdisciplinary
teams provide care to approximately 65% patients each. The average length of stay was 39 days.
The study sample consisted of patients who were receiving hospice home care. The
inclusion criteria for participation were: Patients were identified by admission face sheets as
those who had a cancer diagnosis, had an identified family caregiver, were adults (18+ years
74

old), either male or female, able to read and understand English, and able to pass screening with
the Short Portable Mental Status Questionnaire for cognitive competency (score > 8). Exclusion
criteria were confused, excessively debilitated, comatose or actively dying patients. The original
sample included 709 participants. 533 of them were 65 years or older and were included in this
secondary analysis.
The parent study was approved by the administrators of the involved hospice service and
the University of South Florida (USF) Institutional Review Board for the Protection of Human
Subjects (IRB). The data collectors for patient data were experienced hospice nurses. Baseline
data collection took place after admission to hospice. Patients who met the admission criteria
were asked to fill out their questionnaires during a home visit. Those patients who met sample
selection criteria and signed the informed consent were asked to answer the following
questionnaire: Palliative Performance Scale (PPS), Center for Epidemiological Studies
Depression, Boston Short Form (CESD-10), and the Memorial Symptom Assessment Scale
MSAS. A demographic and clinical survey was completed as well.
Research design.
This study conducted a cross-sectional correlational study using baseline dataset from a
large multicenter parent study (R01/5R01NR008252), of hospice patients with cancer. The
purpose of choosing this design was to examine relationships among variables, so that inference
about symptom cluster relationship with functional status could be made. In addition, as it is the
intent of this study to evaluate the association between multiple fatigue-related symptoms, this
design allows the investigator to compare multiple variables at the same time at no additional
cost.
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Sample.
To be included in this secondary data analysis, the participants’ data had to have met the
inclusion criteria: older adults (65+ years old), males and females, and had completed the MSAS,
CESD-10, and the PPS scales, as well as demographic and clinical survey. The exclusion criteria
were the same as the parent study.
Measures.
Patient demographic/clinical survey. Variables included age, gender, ethnic background,
education level, marital status, living arrangement, cancer type, and length of time since
diagnosis in years. Age was a continuous variable, gender and living arrangement were
categorical variables. Living arrangement had 7 items: “Living alone, living with a spouse, living
with spouse and child, living with the child, living with a parent, living with a roommate, and
living with other”.
Functional status. Palliative Performance Scale (PPS) assessed the functional status of
persons receiving palliative care (Anderson, Downing, Hill, Casorso & Lerch, 1996). It was a
validated measure of performance status, was based on the Karnofsky Performance Scale (KPS)
and was proposed to provide a framework for measuring the progressive decline in palliative
care patients. The PPS measures three broad areas: mobility, intake, and level of consciousness in
five categories (degree of ambulation; ability to do activities and extent of disease; ability to do
self-care; food/fluid intake; and state of consciousness). The PPS was scored from 0-100% at
10% increments (0% = “worse performance vs.100% = “best performance”). The validity of this
instrument was assessed by comparing the PPS score with the length of survival (McMillan et.
al, 2012). The strong positive correlations between PPS and KFS (r=.88-.97, n=23) support
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construct validity. Inter-rater reliability between two raters was strong (r=.95) (McMillan et. al,
2012).
Symptoms. The Memorial Symptom Assessment Scale (MSAS) was designed to
differentiate among frequency, intensity, and distress from symptoms that are commonly
associated with cancer. MSAS demonstrated reliability, validity, and ease of use (Porteney, et al,
1994). The original MSAS has 33 items assessing cancer symptoms. The items are scored by
summing the items in each subscale (i.e., physical, psychological). The higher the score, the
more severe, frequent, or distressing the symptoms are. (Porteney, et al, 1994). A revised MSAS
was used for this study that was developed for use with hospice patients with cancer, retaining
items from the original MSAS that were most relevant to hospice patients’ symptom experience
(McMillan et. al, 2012). A total of 25 items were included in the revised version of the MSAS.
Participants were asked whether they had a symptom or not (symptom occurrence). If their
answer was positive. They were further asked about the symptom severity and distress. Symptom
occurrence was a perception of the symptom frequency in the past 7 days in the MSAS, so this
variable was treated as a continuous variable from 0 (“No”) to 1 (“Yes”). Symptom severity and
distress items were rated from 0-4 for severity and from 0-4 for distress. The scores were
transformed into a 0-100 score respectively. For this secondary data analysis fatigue was
operationally defined as lack of energy in this scale. Assessment of the validity of the MSAS for
use with cancer patients receiving hospice home care was conducted and included correlation
Hospice Quality of Life Index-14 (HQLI-14) scores. The correlation between MSAS distress
scores and HQLI-14 scores were moderately strong and negative (r= -.72; p<.001). This provided
further support for construct validity of the MSAS for use with cancer patients near the end of
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life. In addition, the reliability of the intensity and distress scores were acceptably high
(r=.73-.74) using coefficient alpha.
Depression. Depressive symptoms were assessed using the Center for Epidemiologic
Studies Depression-Boston Short Form (CESD-10) Scale. The CESD-10 is a 10-item, self-report
questionnaire that was developed to measure symptoms of depression in community populations.
It is rated on a dichotomous Yes/No scale (Kohout et al., 1993). CESD-10 scores range from 0 to
30; higher scores indicate higher depressive symptoms. It combines ease of administration and
reduced questionnaire burden with only 2-minutes of administration time. It had a very good
reliability and validity and had been utilized successfully in the assessment of depressive
symptoms in cancer research (Carpenter et al., 1998; Hann, Winter, & Jacobsen, 1999; Stagl, et.
al, 2015; Garrison, Overcash, & McMillan, 2011). The Cronbach’s alpha for this study was .703.
It is expected that shorter scales with fewer items like CESD-10 have lower alpha coefficients,
thus, this result is acceptable.
Procedures.
The study protocol was approved by the University of South Florida IRB. Only baseline
dataset was analyzed in this dissertation study. The recruitment process, study findings, and
limitations of the parent study were discussed with the research team. The data were examined
for completeness.
Data cleaning. To improve the quality of data for advanced analyses, data cleaning was
performed. A common limitation of secondary data analysis is the single data source. Data
quality problems of single data collection include misspellings of variables during data entry,
invalid data, and missing information (Rahm, & Do, 2000). Statistical Package for Social
Sciences SPSS version 25.0 (SPSS, Chicago, IL, USA) was used to detect and remove errors and
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discrepancies. The parent study sample included patients who were 18 years and older, the parent
study data file was split into 64 ≤ and 65 ≥ years. The current data analyses included only
participants that were 65 years and older. The new data file (N= 533) had a substantial amount of
missing data on MSAS severity and distress scale. A major problem with using the MSAS was
that the symptom severity or distress items were dependent on the occurrence items. This meant
that if there was no symptom occurrence, both symptom severity or distress would not be
answered which led to a large amount of missing data. For that reason, we limited the analyses to
include MSAS symptom occurrence. Furthermore, the dummy coding method was used to
transform categorical variables. Variables with “0” entry were excluded from the analysis
because they were missing data. One item of living arrangement, “live with a parent,” was
considered to not appropriate for the target population, because very few older adults still live
with parents. This item was removed from analyses. For the remaining variables, missing data
were managed with pairwise deletion techniques assuming that data were missing completely at
random. After data cleaning, 519 cases were available for data analyses.
Data analyses.
Descriptive statistics were used to analyze the demographic and clinical variables. For the
first research question, bivariate Pearson correlations were used to explore the relationships
among study variables and identified the symptoms which correlations reached statistical
significance with fatigue. MSAS occurrence symptoms were clustered by exploratory factor
analysis (EFA) extraction method used was principal component analysis (PCA) of the Statistical
Package for the Social Sciences (SPSS) version 25 (SPSS Chicago, IL, USA). We used oblique
rotation methods, (direct Oblimin and Promax), as we hypothesized to have nonzero correlations
among the factors and aim to make inferences about physical and psychological symptoms
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relationships, orthogonal rotations may be inappropriate. The number of factors extracted was
determined using the eigenvalue 1.0, a scree plot, and parallel analysis with the Monte Carlo data
simulation technique.
For the second research question, first, bivariate correlations were conducted among
fatigue-related symptoms clusters (mean of clustered symptoms cooccurrence), depression
(CESD_10), and functional status (PPS). Second, hierarchal multiple regressions with a
functional status variable as the outcome variable were applied. In the first step, the predictor
variable was fatigue related symptom cluster. In the second step, the predictor variable was
fatigue related symptom cluster controlling for age, gender, and living arrangement. In the third
step, the predictor variable was fatigue related symptom cluster controlling for age, gender,
living arrangement, and depression.
Results
Sample characteristics.
The sample included 519 hospice patients. The mean age of the sample was 78.13 years,
(SD= 7.4), with a mean of 12.6 years of education (SD= 3.1 years). Fifty-seven percent of the
participants were males. Ninety-seven percent were Caucasian. The majority of the patients were
partnered (64%) and living with spouse/partner. Cancer diagnoses included lung (n=193, 36%),
pancreas (n=50, 9.4%) colon (n=39,7.3%), prostate (n=36, 6.8%), and breast (n=25, 4.7%)
among others (n=147, 27.5%), with a mean of 2.25 years from diagnosis (SD= 4.1). The average
CESD-10 score was 2.89 (SD= 2.2). In the MSAS, the total number of symptoms had a mean of
9.63 (SD= 4.19). The average of total PPS scores was 56.83 (SD= 10.72). Sample characteristics
are presented in Table 3.1.

80

Research Question 1: which symptom relationships identify fatigue-related symptom cluster?
Relationships among symptoms.
Fatigue (lack of energy) had a significant positive correlations with the following items in
relationship strength order: lack of appetite (r= .267, p=<05), feeling drowsy (r=.220, p<.05) lack
of concentration (r=.164, p=<05), shortness of breath (r=.132, p<.05), dizziness (r=128, p<.05),
feeling sad (r=.127, p=<05), feeling irritable (r=.126, p=<05), nausea (r=.122, p<.05), dry mouth
(r=.117, p<.05), feeling nervous (r=.115, p=<05) problems with sex (r=.101, p<.05), problems
with urination (r=.097, p<.05), and sweats (r=.091, p<.05). Lack of energy had appositive
correlation with CESD-10 (r=.217, p<.01). (Table 3.2).
Currently, in symptom cluster research, there are no standard or cutoff points for a
symptom to be included in a cluster (Dong et. al. 2014). However, it is generally agreed that
symptoms should moderately correlate with each other (r=.30–.70) (Chan, Richardson, A., &
Richardson, J., 2005). However, all the Pearson correlations were less than 0.3 in the results.
Therefore, 0.2 of Pearson r was set for clustered symptom selection. As a result, fatigue-related
symptoms cluster identified in this analysis included lack of energy, feeling drowsy, and lack of
appetite. In the total of 519 participants, there were 201 (39%) who reported lack of energy,
feeling drowsy, and lack of appetite simultaneously.
Symptom Clusters.
Due to the low Pearson correlations for the three clustered symptoms. This cluster was
further examined by conducting EFA to check if these three symptoms clustered in one factor.
Initially, the data suitability for the cluster analysis was examined. MSAS symptom occurrence
for this sample (N=519) was reliable. The average inter-item Cronbach’s alpha coefficient of
reliability was .735. The determinant of the correlation matrix approached zero (.076). The
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Kaiser-Meyer-Olkin Index of Sampling Adequacy was .761. Finally, the Bartlett's Test of
Sphericity was significant (2 = 1318.530, df = 231, p < .001). Based on these criteria, the interitem correlation matrix was deemed adequate for factor analysis. Four symptom clusters were
identified, with 40.837% of the variance explained, the symptom cluster PCA factor structure
with the solution is presented in Table 3.3.
On Factor 1, seven symptoms (worrying, feeling sad, feeling irritable, feeling nervous,
difficulty concentrating, problem with sex, and feeling drowsy) loaded together, which explained
15.470% of the factor’s variance. Cronbach’s alpha coefficient, for this cluster, was 0.63 which
indicated the symptoms within cluster occurred in a homogeneous pattern. This factor was
labeled “psychological.” However, one symptom (feeling drowsy) loaded on both Factor 1 and
Factor 3. The loading score for feeling drowsy was higher for Factor 3 than Factor 1, suggesting
it was a stronger symptom indicator for Factor 3 and it was excluded from Factor 1 accordingly.
Thus, only six of the seven symptoms (worrying, feeling sad, feeling irritable, feeling nervous,
difficulty concentrating, problem with sex) were considered as indicators of Factor 1.
On Factor 2, four symptoms loaded together (nausea, vomiting, pain, sweats, and lack of
appetite) which explained 7.058% of the factor’s variance. Cronbach’s alpha coefficient for this
cluster was 0.607 which indicated the symptoms within the cluster occurred in a homogeneous
pattern. Factor 2 was labeled “pain, gastrointestinal”.
On Factor 3, nine symptoms (constipation, lack of appetite, feeling bloated, difficulty
sleeping, dry mouth, lack of energy, feeling drowsy, problems with urination, dizziness) loaded
simultaneously, which explained 6.007% of the factor’s variance. Cronbach’s alpha coefficient
for this cluster was 0.472 which suggested the symptoms within cluster occurred in a
homogeneous pattern. However, as previously mentioned the symptom (feeling drowsy) loaded
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on both Factor 1 and Factor 3. The loading score for feeling drowsy was higher on Factor 3 than
Factor 1 and was retained as an indicator of the symptom cluster for Factor 3. Factor 3 was
labeled “somatic vegetative”. At the same time, Factor 3 supported that fatigue-related cluster
contained the three symptoms (lack of energy, feeling drowsy, and lack of appetite) found in the
Pearson correlations.
On Factor 4, four symptoms (dizziness, shortness of breath, cough, difficulty swallowing)
loaded together, which explained 5.451% of the factor’s variance. Cronbach’s alpha coefficient
for this cluster was 0.444 which suggested the symptoms within cluster occurred in a
homogeneous pattern. However, the symptom (dizziness) loaded on both Factor 3 and Factor 4.
The loading score for dizziness was higher for Factor 3 than Factor 4, suggesting it was a
stronger indicator for Factor 3 than Factor 4 and so it was eliminated from Factor 4 and retained
as an indicator of the symptom cluster for Factor 3. This resulted in three symptoms being
considered as indicators of Factor 4. Factor 4 was labeled “dyspnea, throat”. Symptom clusters
factor correlation matrix is presented in Table 3.4.
Research Question 2: To which extent fatigue-related symptom clusters predict functional status
while controlling for depression?
Fatigue, depressive symptoms, and functional characteristics.
On average, older adult hospice patients experienced 9 concurrent symptoms (SD= 4.2),
and the prevalence of fatigue (lack of energy) was 86.9%. Approximately 34% of the patients
reported feeling depressed, and 37.6% felt sad. FSC reached a negative low but highly
significant correlation (r = -.117 p=.008) with the functional status measure PPS, and positive
significant correlation with CESD-10 (r=253, P<.000). Also, depressive symptoms CESD-10 had
a negative low and significant correlation with PPS (r= -.096, p=.027).
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Predictors of functional status.
Hierarchical multiple regression was performed to investigate the ability of fatiguerelated symptom cluster (lack of energy, feeling drowsy, and lack of appetite) to predict
functional status, after controlling for depressive symptoms. The first step of the hierarchal
regression conducted with the independent variable fatigue related symptom cluster regressed
onto functional status explained 1.2 % of the total variance of the PPS scores (R2=.012, F (1,515)
=7.113, p = .008). To control for confounding variables that correlate with functional status, a
second step of the hierarchal regression was conducted controlling for age, gender and living
arrangement. The second model of the hierarchical regression, F (8,508) =.176, p =.000, FSC
significantly predicted PPS accounting for 4.5% of the variance controlling for age, gender, and
living arrangement.
In an attempt to further the investigation of functional status predictors, as the fatiguerelated symptom has a significant positive correlation with CESD-10. The third step, depressive
symptoms CESD-10 total scores were entered as a covariate variable, in addition to FSC, age,
gender, living arrangement variables. The third model increased the functional status
predictability of fatigue-related symptom cluster by 3.5 points, (R2 Δ= .047 - .012= .035), which
was a small but a significant change (FΔ=4.983, df 1,507, P<.05).
Discussion
This study aimed to identify fatigue-related symptom cluster in older adult hospice
patients with cancer and to evaluate the extent to which the identified cluster and depression can
predict functional status. The correlation analysis revealed three clinically relevant symptoms of
fatigue: lack of energy, feeling drowsy, and lack of appetite. Atkas, Walsh, and Hu (2014), as
well as Van Lancker et al., (2016), had recently reported similar clustering with fatigue. The
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relationship between fatigue and feeling drowsy is suggested to be indicative of a
parasympathetic nervous system dysfunction (Van Lancker et al., 2016). On the other hand, the
lack of appetite can result in loss of energy and feeling of weakness that can be linked to
functional status decline. A clinically and statically significant predictive relationship that was
confirmed in our regression analysis. This close direct linkage of fatigue symptom cluster and
functional status, however, only accounted for a small (1.2%) portion of the total variance in PPS
scores. The increase in total variance explained by fatigue-related cluster (4.7%), which further
supports the independent negative relationship of fatigue-related symptom cluster with functional
status. Also, a trend was observed in the patients’ age and living arrangement differences,
suggesting that younger patients who lived with children may report more fatigue-related
symptoms, higher depression and lower functional status. An explanation of such a trend is
possibly related to older adults’ fewer reports of symptoms severity and distress. It could also be
inferred that living with adult children comes with many stresses and it may involve living with
grandchildren and married children. Although living alone presents its own set of challenges,
such as needing a caregiver. Perhaps old age among many virtues come with better and more
effective coping skills. Finally, even though we used Pearson correlation coefficients to identify
the symptom cluster, our study was able to confirm the finding with further factor analysis, and
replicate findings of the literature specific to fatigue-related symptom clusters (Aktas, Walsh, &
Hu, 2014; Van Lancker et al., 2016).
There have been some pilots and studies on more effective symptom management for a
single symptom, such as physical activity interventions. However, we are still in a rudimentary
phase researching the more precise ways to identify symptom clusters and their predictive
tendencies on the various cancer patients’ functional status. Therefore, research remains limited
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and requires continuous longitudinal and empirical case evaluations. However, as it stands,
research beckons a need for a shift in paradigm, in the overall palliative care management, to
refocus its lens on the more psychological aspects of the patients’ difficult experience. Education
on physical symptom attributes, no matter what the recurring clusters, are only a primary catalyst
of an overarching theme; that is, the effect of psychological distress on worsening or even
expediting the inevitable physical symptoms. A similar linkage of physical and psychological
symptoms is evident in symptom science literature, Kwekkeboom (2016) found that fatigue,
pain, and anxiety were tremendously increased in those participants undergoing chemotherapy
with little to no social support. Symptom experience begins with the occurrence, first, the
perception of a change is noted. However, the actual experience lies in the process of evaluation
and response. The judgment of the physical symptom severity, frequency and location is what
evokes the subjective psychological, physiological or behavioral response. The symptom
assessment scale must capture the full experience feelings, thoughts, and behaviors related to the
symptom experience. The reason fatigue was not clustered with pain, depression, or sleep
disturbance is perhaps a limitation of the way fatigue was defined, relying on lack of energy
symptom occurrence only.
Recent studies in cancer patients of urban settings attempted to distinguish symptoms
between minorities and Caucasians and while concluded there was currently none but not enough
long-term research to validate this definitively adds another layer of research needed.
Furthermore, the findings emphasize the necessity of educating patients as well, involving them
in their own ability to identify the concurrent symptoms and potential extraneous catalysts that
may exacerbate or conversely ameliorate these symptoms. Implications for nurses is to be as
informed as possible of potential high-risk predictors directly related to the psychosocial aspect
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of the patient. Therefore, increased proper tracking of physical symptoms in tandem with
psychological impacts on the symptoms themselves.
Conclusions
Current research is indicating three important gaps that may be considered for further
investigations in future research:
1. More statistical and scientific derivations for assessing symptom clusters and their
predictive impacts on functional status, in the progressive stages of the hospice patients,
would better assist methodical guidance in symptom management.
2. Emphasis on the psychosocial impacts needs to be better addressed and reviewed, as well
as new interventions to facilitate and ameliorate symptom cluster management.
3. While not discussed much in this review, biological underpinnings need to be further
investigated both on how it impacts predictive symptom clusters as well as more ethnic
and cultural implications of psychosocial symptoms experienced.

References
Anderson, F., Downing, G.M., Hill, J., Casorso, L., Lerch, N. (1996). Palliative performance
scale (PPS): a new tool. Journal of Palliative Care. 12, 5‐11.
Aktas, A., Walsh, D., & Hu, B. (2014). Cancer symptom clusters: an exploratory analysis of
eight statistical techniques. Journal of pain and symptom management, 48(6), 1254-1266.
Beck, S. L., Towsley, G. L., Caserta, M. S., Lindau, K., & Dudley, W. N. (2009). Symptom
Experiences and Quality of Life of Rural and Urban Older Adult Cancer Survivors.
Cancer Nursing, 32(5), 359–69. doi:10.1097/NCC.0b013e3181a52533
Chan, C. W. H., Richardson, A., & Richardson, J. (2005). A study to assess the existence of the
symptom cluster of breathlessness, fatigue, and anxiety in patients with advanced lung
cancer. European Journal of Oncology Nursing, 9(4), 325–333.
https://doi.org/10.1016/j.ejon.2005.02.003

87

Cheng, F., & Lee, F. (2011). Effects of Pain, Fatigue, Insomnia, and Mood Disturbance on
Functional Status and Quality of Life of Elderly Patients with Cancer. Critical Reviews in
Oncology/Hematology, 78(2), 127–37. doi:10.1016/j.critrevonc.2010.03.002
Costarella, M., Monteleone, L., Steindler, R., & Zuccaro, S. (2010). Decline of Physical and
Cognitive Conditions in the Elderly Measured Through the Functional Reach Test and
the Mini-Mental State Examination. Archives of Gerontology and Geriatrics, 50(3), 332–
337. doi:10.1016/j.archger.2009.05.013
Francoeur, R. B. (2014). Using an innovative multiple regression procedure in a cancer
population (Part II): Fever, depressive affect, and mobility problems clarify an influential
symptom pair (pain-fatigue/weakness) and cluster (pain-fatigue/weakness-sleep
problems). Oncology Targets and Therapy, 8, 57–72.
https://doi.org/10.2147/OTT.S68859
Karnofsky, D., Burchenal, J. (1949). The clinical evaluation of chemotherapeutic agents in
cancer. In MacLeod C. M. (Eds.), Evaluation of chemotherapeutic agents (pp. 191-205).
New York, NY: Columbia University Press.
Kim, H. L., Puymon, M. R., Qin, M., Guru, K., & Mohler, J. L. (2014). NCCN Clinical Practice
Guidelines in Oncology.
Kwekkeboom, K. L. (2016). Cancer Symptom Cluster Management. Seminars in Oncology
Nursing, 32(4), 373–382.
Lengacher, C. A., Reich, R. R., Post-White, J., Moscoso, M., Shelton, M. M., Barta, M., …
Budhrani, P. (2012). Mindfulness based stress reduction in post-treatment breast cancer
patients: An examination of symptoms and symptom clusters. Journal of Behavioral
Medicine, 35(1), 86–94. https://doi.org/10.1007/s10865-011-9346-4
McMillan, S. C., Small, B. J., & Haley, W. E. (2012). Improving hospice outcomes through
systematic assessment: A clinical trial. Cancer Nursing, 34(2), 89–97.
https://doi.org/10.1097/NCC.0b013e3181f70aee.
National Hospice and Palliative Care Organization (NHPCO): Facts and Figures Hospice Care in
America. Version 2018. Available at: https://www.nhpco.org/hospice-statistics-researchpress-room/facts-hospice-and-palliative-care.
Payette, H., Gueye, N., Gaudreau, P., Morais, J., Shatenstein, B., & Gray-Donald, K. (2011).
Trajectories of Physical Function Decline and Psychological Functioning: The Québec
Longitudinal Study on Nutrition and Successful Aging (NuAge). The Journals of
Gerontology, Series B: Psychological Sciences and Social Sciences, 66(S1): i82–i90.
doi:10.1093/geronb/gbq085
Rahm, E., & Do, H. H. (2000). Data cleaning: Problems and current approaches. IEEE Data
Engineering Bulletin, 23(4), 3-13.

88

Reich, R. R., Lengacher, C. A., Alinat, C. B., Kip, K. E., Paterson, C., Ramesar, S., … Park, J.
(2017). Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients:
Immediate and Sustained Effects Across Multiple Symptom Clusters. Journal of Pain
and Symptom Management, 53(1), 85–95.
Siegel R., Miller K., Jemal A. (2018). Cancer Statistics, 2018. CA Cancer Journal for Clinicians,
68(1),7-30. doi:10.3322/caac.21442.
Thomas, B. C., Waller, A., Malhi, R. L., Fung, T., Carlson, L. E., Groff, S. L., & Bultz, B. D.
(2013). A Longitudinal Analysis of Symptom Clusters in Cancer Patients and Their
Socio-demographic Predictors. Journal of Pain and Symptom Management.
doi:10.1016/j.jpainsymman.2013.04.007

89

Table 3.1 Demographics and Clinical Characteristics of Patients

Age
Gender
Male
Female
Marital status
Never married
Currently married
Separated
Divorced
Widowed
Ethnicity
Caucasian
African American
Hispanic
Asian/pacific islander
other
Years of formal education
Cancer diagnosis
Lung
Pancreas
Colon
Prostate
Breast
other
Years since diagnosis
Living arrangement
Alone
Spouse/partner
Spouse/partner and children
Children (no spouse/ partner)
Roommate (no spouse/ partner)
other
Cancer symptoms
Lack of energy (yes)
Pain at all (yes)
Difficulty sleeping (yes)
Depression (CESD-10)
Functional status (PPS)

Frequency

Percent

300
219

57.8
42.2

18
332
4
42
122

3.5
64.0
.8
8.1
23.5

503
8
5
1
2

96.9
1.5
1.0
.2
.4

8.65
188
49
39
32
23
329

8.719
36.2
9.4
7.5
6.2
4.4
63.8

39
342
19
46
5
68

7.5
65.9
3.7
8.9
1.0
13.1

451
363
202

86.9
69.9
38.9

90

Mean
78.18

Std. Deviation
7.351

12.61

3.121

2.27

4.16

2.89
56.83

2.2
10.72

Table 3.2 Bivariate Correlations Matrix of Study Variables with Fatigue Symptom Cluster.

age
gender
PPS
CESD-10
FSC
MSAS severity
MSAS distress
MSAS occurrence
Living arrangement

Age
1

Gender

-.063
-.036
-.045
-.171**
-.181**
-.179**
-.206**
-.002

1
-.066
.021
-.005
.017
.025
-.007
.251**

PPS

1
-.096*
-.117**
-.114**
-.103*
-.046
.153**

CESD -10

1
.253**
.443**
.451**
.421**
-.045

FSC

1
.548**
.479**
.617**
-.103*

MSAS
severity

1
.887**
.882**
-.026

MSAS
MSAS
living
distress occurrence arrangement

1
.820**
-.052

1
-.028

Mean
78.18

SD
7.34

.43
57.05
2.84
2.07
20.49
19.72
9.65

.49
10.72
2.15
.90
11.14
13.43
4.10

1

*N=533; *Correlation is significant at the 0.01 level (2-tailed). **Correlation is significant at the 0.05 level (2-tailed). PPS=palliative performance scale;
functional status measure, CESD-10=Center for Epidemiological Studies Depression, Boston Short Form, FSC= fatigue-related symptom cluster.
MSAS=Memorial Symptom Assessment Scale.
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Table 3.3 Symptom Clusters Structure Matrix
Symptom experiences

Factors
Factor 2
Factor 3

Factor 1
.688
.684
.612
.580
.532
.337

worrying
feeling sad
feeling irritable
feeling nervous
difficulty concentrating
prob with sex
nausea
vomiting
pain
sweats
constipation
lack of appetite
feeling bloated
difficulty sleeping
dry mouth
fatigue; lack of energy
feeling drowsy
problems with urination
dizziness
shortness of breath
cough
difficulty swallowing
Variance explained

Factor 4

.817
.785
.542
.412
.500
.489
.483
.476
.460
.455
.417
.370
.341

15.470%

7.058%

6.007%

.726
.703
.459
5.451%

33.987%

Total Variance explained

Table 3.4 Symptom Clusters Factor Correlation Matrix

Factor 1
Factor 2
Factor 3
Factor 4

Factor 1
1.000
.278
.324
.235

Factor 2

Factor 3

Factor 4

1.000
.270
.168

1.000
.229

1.000

*Factor 1 = “psychological”. Factor 2 = “pain, gastro-intestinal”. Factor 3 = “somatic, vegetative, physical.
Factor 4 = dyspnea, throat). Extraction Method: Principal Component Analysis. Rotation Method: Promax with
Kaiser Normalization.
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Table 3.5 Hierarchal Multiple Regression Predicting Functional Status
Model
Step 1

Step 2

Step 3

(Constant)
FSC

B
59.50
-1.38

Std.
Error
1.169
.520

(Constant)
FSC
Living other
age
gender

67.39
-1.406
6.188
-.098
-2.489

(Constant)
FSC
Living other
age
gender
CESD-10 Total

67.844
-1.209
6.164
-.097
-2.425
-.336

β

Adjusted R
Square

Std. Error of
the Estimate

R Square
Change

.012

10.755

.014

.000
.008
.000
.140
.016

.045

10.575

.046

.000
.026
.000
.145
.019
.128

.047

10.561

.004

-.117

t
50.877
-2.667

Sig.
.000
.008

5.482
.527
1.464
.066
1.034

-.118
.193
-.067
-.114

12.294
-2.668
4.227
-1.479
-2.407

5.483
.542
1.462
.066
1.033
.220

-.102
.193
-.066
-.111
-.068

12.374
-2.232
4.216
-1.460
-2.347
-1.524

*PPS=palliative performance scale, CESD-10=Center for Epidemiological Studies Depression, Boston Short Form, FSC= fatigue-related symptom cluster.
Dependent Variable: PPS Total
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Summary of Dissertation
Discussion
This dissertation study explored the relationships between fatigue, depressive symptoms
and functional status in older adults with cancer. Guided by the Theory of Unpleasant
Symptoms, our framework postulated that fatigue in cancer is a physical symptom and has
interrelations with other cancer symptoms; fatigue related symptom clusters. Depression is
considered a psychological symptom in the conceptual framework. Patient contextual factors
influence the experience of fatigue-related symptom cluster and depression. Functional status is
an outcome of the symptom experience.
In the first section of the dissertation, we summarized the current science stands on
fatigue in the older adult cancer population, in relation to physical activity interventions, and
explored functional status outcomes. There is evidence that moderate to intensive physical
activity interventions are well tolerated by older adults. Motivation and adherence were also
similar to their younger counterparts. The interventions showed significant improvements in
fatigue cancer symptom. Objective improvements were also evident in measures of functional
status, including muscle strength, mass, and endurance, balance, peak oxygen uptake reflecting
increases in physical and functional capacity.
There is yet a lack of consonance on the measures of fatigue, and specifics of exercise
modalities, and duration. An important aspect of the Theory of Unpleasant Symptoms is
symptom defined in multidimensional measures, including intensity, distress, frequency, and
interference. Therefore, a multidimensional symptom as fatigue should be captured with a scale
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that considers fatigue-related symptom cluster. Interventions that included behavioral aspects
and counseling could benefit patients with depression. Also, future physical activity
interventions should adhere to the American College of Sports Medicine guidelines when
prescribing physical activity programs to maintain adequate levels of intensity, duration, and
frequency that are appropriate for the older adult cancer patients for the purpose of producing the
desirable positive and significant health improvements.
Because depression, as a psychological symptom, was detected by many previous cancer
studies as a core component of symptom clusters, in the second dissertation section we examined
the Center for Epidemiological Studies Depression, Boston Short Form (CESD-10). We
confirmed CESD-10 has appropriate structural validity. The reliability for use to assess
depression in patients with cancer was also satisfactory. Physical symptoms, such as fatigue, are
linked to emotional distress which negatively affects functional status. Both physical and
psychosocial symptoms and symptom clusters have a direct and indirect impact on quality of
life, supporting the urgency to understand the relationship between depression, fatigue, and
functional status.
In the third dissertation section, we examined the relationship of fatigue to cancer-related
symptoms and identified a fatigue-related cluster of symptoms (feeling drowsy, lack of energy,
and lack of appetite) that was evident in prior research as well. Depression was positively
associated with fatigue-related symptom cluster, and negatively with functional status. While
functional status was operationalized as scores of PPS. Both fatigue related symptom cluster and
depression were significantly associated with PPS. Experiencing fatigue-related symptom cluster
was a predictor of participants’ low functional status, and depression had a significant
contribution to this predictive relationship. Although one can argue the effect of sample size in
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producing inflated results, this relationship is evident in clinical context and prior research.
A common limitation of secondary data analysis studies is the constrain researchers to
have towards the choice of instruments. Probably conceptualizing fatigue as lack of energy does
not capture the full dimensions of fatigue symptom, which may explain the weak but significant
results of this dissertation. In future studies, researchers should consider using a valid and
reliable fatigue measurement scale. A multi-symptom measure that lacks a specific fatigue
subscale may contribute to the weak correlations with the functional status outcome we found.
This study is informative of the potential significant predictors of functional status directly
related to the physical and psychological aspects of the patient. Therefore, clinicians and
researchers alike should gain increased sensitivity and proper detection of cancer symptoms in
tandem with their psychological impacts.
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